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Abstract 
RNA-PROCESSING GENES CONTROL SENSORY NEURON FUNCTION IN 
DROSOPHILA MELANOGASTER 
Amber Dawn Dyson 
B.S., Thomas Edison State College 
M.S., Appalachian State University 
 
 
Chairperson: Dr. Andrew Bellemer 
 
 
Chronic pain affects approximately 100 million Americans and generates costs of up 
to $600 billion per year, according to the Institute of Medicine. Characterization of molecular 
signaling pathways in sensory neurons is an important step toward development of more 
effective clinical interventions. The goal of this study was to identify genes involved in 
regulating the function of class IV multidendritic neurons (nociceptors) integral to the 
detection of thermal, mechanical, and photic stimuli. We used Drosophila melanogaster 
larvae as a model organism, which exhibit a distinct and quantifiable response to noxious 
stimuli termed nocifensive escape locomotion (NEL). Recent research has found that the 
transcripts of key genes necessary for nociceptor function are alternatively spliced, indicating 
the dependence of function on expression patterns. We systematically knocked down putative 
RNA-processing genes with a previously identified role in dendrite development and/or 
alternative splicing by crossing a ppk-GAL4;UAS-dicer2 fly strain with RNAi lines targeting 
genes of interest. Using ppk as our driver limits expression to nociceptors 
and dicer2 promotes increased expression of RNAi transcripts. We then tested progeny for 
changes in nocifensive response latency relative to wild-type larvae using a thermal 
nociception assay. Twenty-five genes were identified for which knockdown resulted in either 
v 
a significant increase or decrease in response latency, indicating a potential defect. Follow-up 
assays validated seven genes with an insensitive phenotype and two with a hypersensitive 
phenotype. Additionally, our results have confirmed that behavioral defects do not correlate 
with defects in dendrite morphology. Finally, a complex role for translation initiation factors 
was revealed, suggesting the potential for a nociception-specific and possibly IRES-mediated 
translation mechanism involving eIFG2 and eIF4E3. 
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Introduction 
 
The Affordable Care Act (2010) included a directive that the Department of Health 
and Human Services enlist the Institute of Medicine (IOM) in examining the problem of 
clinical pain (Institute of Medicine, 2011). In their report, the IOM detailed the associated 
costs and compelling need for improvement in treatment options and explicitly stated the 
necessity of prioritizing pain-related research. The report also addressed the serious 
complications and consequences resulting from the broad application of opioids in treating 
pain. Developing the new classes of pain medication recommended by the IOM will require 
significant advancement in our understanding of the molecular signaling pathways involved 
in nociception. Nociception refers to the ability to perceive noxious stimuli, which 
encompasses all types of stimuli that provoke a pain response, indicating to an organism that 
an aspect of the environment is dangerous (Bessou and Perl, 1969). Nociceptors are the 
specific class of sensory neurons integral to sensing pain (Sherrington, 1906). 
Drosophila melanogaster serve as an excellent model organism for studying this 
aspect of the nervous system for several reasons, including similarity of sensory neuron 
structure and function, conservation of genes, and ease of testing. The multidendritic (md) 
neurons of the Drosophila peripheral nervous system include the dendritic arborization (da) 
neurons, the dendrites of which spread throughout the epidermis between the epithelium and 
muscle. Drosophila md-da neurons are divided into four groups based on type-specific 
dendrite morphology, designated Class I, II, III, and IV, which are arranged in a specific 
design repeated in each abdominal hemisegment (Jan and Jan, 2010). Class IV neurons are 
polymodal nociceptors (Hwang et al., 2007; Tracey et al., 2003). The stereotyped patterning 
across segments makes any defects in dendrite morphology readily apparent. From a 
2 
behavioral perspective, Drosophila perform a unique and specific “rolling” behavior when 
noxious stimuli are perceived, termed nocifensive escape locomotion (NEL), which gives 
researchers a distinct marker for obtaining quantifiable data to measure response to noxious 
stimuli (Hwang et al., 2007; Tracey et al., 2003).  
Additionally, a large proportion of genes with a role in the Drosophila nervous 
system encode proteins that are well conserved in vertebrates. For example, TrpA1 encodes 
proteins that form ion channels found in class IV neurons that are necessary for nociception 
function. The transient receptor potential (TRP) family of proteins is conserved with similar 
functionality in vertebrates, including humans, making Drosophila an effective model 
organism for pain-related research (Zhong et al., 2012). Finally, Drosophila are highly 
amenable to genetic manipulation. Using the UAS/GAL4 system with RNAi for targeted 
genes allows for effective knockdown of function. A variety of promoters can be used to 
limit the expression of RNAi to specific cells. For instance, using the ppk-GAL4 transgene 
limits expression of RNAi solely to nociceptors (Zhong et al., 2010). 
Previous research has established that proper nociception function is affected by 
alternative splicing of relevant gene transcripts (Hulse et al., 2014; Jiang et al., 2013; Nakae 
et al., 2013; Thackeray and Ganetzky, 1994; Zhong et al., 2012), and that genes necessary for 
dendrite development are alternatively spliced (Jan and Jan, 2010), but little is known about 
possible splicing regulatory proteins involved. Regulation could be occurring at one or more 
points during the many steps of mRNA processing and subsequent translation, including 
capping, polyadenylation, alternative splicing, and translation initiation. RNA-processing 
genes play a variety of important roles throughout these steps, and studying ways in which 
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NEL behavior is affected by these mechanisms could illuminate the roles of RNA processing 
in sensory neurons. 
The Role of mRNA Processing in Protein Availability and Cell Function 
 In eukaryotic organisms, any given cell’s identity and specific functions are 
dependent on the gene expression profile unique to a specific cell or tissue type. The first 
step in characterizing this profile is identifying which genes are transcribed. Of equal 
importance to shaping a cell’s identity are the abundance and specific function of resulting 
proteins, both of which are controlled to a great extent by additional steps taken with 
transcripts that produce a mature mRNA strand.  The three stages of mRNA processing are 5’ 
capping, alternative splicing, and 3’ polyadenylation. 
 It is important to note that these modifications occur in conjunction with transcription 
rather than after transcription is complete and that all mRNA molecules are ready for 
translation prior to export from the nucleus (Bentley, 2005). The RNA polymerase II protein 
(RNAPII) includes a C-terminal domain (CTD) forming a “tail” that carries proteins and 
enzymes used to modify pre-mRNA, an association that facilitates the interaction of 
processing enzymes and proteins with the RNA and increases the efficiency of these 
modification reactions as the new transcript is synthesized. Each of the three processing 
stages requires a different assembly of enzymes and proteins. The phosphorylation state of 
the CTD changes to reflect the processing stage taking place, which serves a regulatory role 
in recruitment of the appropriate factors for each stage (Phatnani and Greenleaf, 2006). 
Identification of cell-specific factors affecting variations in mRNA processing and 
subsequent impact on cell function begins with understanding the role and mechanisms of 
these modifications.  
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Capping is a form of mRNA modification that contributes to control of expression 
levels through facilitation of translation. Soon after transcription of a new pre-mRNA strand 
has begun, the 5’ end of the nascent strand is capped through removal of a phosphate and 
addition of a methylated guanine nucleotide. Three enzymes associated with the CTD (a 
phosphatase, a guanyl transferase, and a methyl transferase) are positioned to enable capping 
as soon as the 5’ end exits RNAPII. Many different types of RNA are produced in the 
nucleus and this cap both identifies mRNA molecules and serves as a binding site for 
proteins that export mRNA from the nucleus for translation (Hashimoto and Green, 1976; 
Moss and Koczot, 1976). The 5’ cap is also a recognition site for translation initiation factors, 
along with the 3’ poly-A tail described below, helping to ensure that only complete and intact 
mRNA strands are translated into proteins (Gross et al., 2003; Marcotrigiano et al., 1999). 
 Polyadenylation helps determine the longevity of a transcript within the cell and 
interacts with important proteins during translation. This process takes place at the 3’ end as 
transcription of the strand is finishing. The CTD of RNAPII functions to facilitate the process 
in a manner similar to 5’ capping. Two proteins, CstF (cleavage stimulation factor) and CPSF 
(cleavage and polyadenylation specificity factor) move from the CTD to the mRNA strand 
once it exhibits the appropriate sequence. CstF and CPSF bind to this sequence along with 
additional cleavage factors. Synthesis of the poly-A tail is then performed by the enzyme 
poly-A polymerase (PAP), which ligates adenine nucleotides to the 3’ end of mRNA. This 
process does not require a template; therefore, the length of the poly-A tail for any given 
transcript is not encoded in its associated gene. Instead, the length is determined at least in 
part by poly(A)-binding protein (PAB), which forms a complex during RNA processing with 
CPSF, PAP, and the mRNA strand. The length of the tail is variable between transcripts and 
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developmental stages, and the mechanism for length determination is not well understood 
(Colgan and Manley, 1997; Proudfoot, 2004). All mRNA molecules are degraded over time 
in the cell’s cytoplasm, so the length of the poly-A tail helps determine how long the 
transcript will be available for translation, thereby directly affecting expression levels of the 
resulting protein (Kornfeld et al., 1989). 
 Alternative splicing is a modification that helps to shape cell function by enabling the 
cell to derive a variety of unique gene products from a single gene, all with distinctly 
different functions. This process involves picking and choosing which coding regions to 
include (exons) and usually eliminating noncoding regions (introns) from the length of the 
mRNA strand. The vast majority of eukaryotic genes are alternatively spliced to some 
degree, and most proteins are the product of alternative splicing rather than straightforward 
translation of entire gene transcripts. Alternative splicing allows the production of a diverse 
range of necessary proteins with differing functions specific to the differential 
inclusion/exclusion of exons and the resulting amino acid composition they code for (Black, 
2003; Chow et al., 1977). 
 One example of an alternatively spliced gene is slob, which encodes the protein that 
binds to and regulates the SLOWPOKE calcium-activated potassium channel. Isoforms 
SLOB57 and SLOB71 have opposite effects on the potassium channel, depolarizing and 
polarizing respectively. Additionally, neurons in the Drosophila brain express SLOB57, 
whereas motor neurons in the neuromuscular junction express SLOB71. Alternatively spliced 
isoforms of the single gene, slob, are thus a key component of the differing function of these 
two neuron types (Jepson et al., 2013). 
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 Many molecular variables contribute to the process of alternative splicing, which is 
performed by a group of RNA molecules collectively termed the spliceosome. The primary 
components of this assembly are five small nuclear ribonucleoproteins (snRNPs), each of 
which is formed by a small nuclear RNA (snRNA) in complex with protein subunits. Each 
intron on the pre-mRNA strand has a splicing site sequence near each end as well as a branch 
point, which is the site where the cleaved 5’ end of the intron will be bound, producing a 
lariat shape  (Black, 2003; Staley and Guthrie, 1998). 
 The basic steps of a splicing event to remove an intron begin with the U1 snRNP 
recognizing the 5’ splice site via base pairing while the branch-point binding protein (BBP) 
and U2 auxilliary factor (U2AF) do the same at the branch-point site. The U2 snRNP takes 
the place of the BBP and U2AF, forming its own base pairings with the pre-mRNA. This 
recognition redundancy improves the accuracy of appropriate site selection. U2 binding to 
the branch-point site causes a single adenine to become unpaired and activated. Then, the 
“triple snRNP” U4/U6-U5 becomes part of the reaction. The U4 and U6 snRNPs are bound 
tightly via base pair interactions, whereas U5 is more loosely associated. When the triple 
snRNP joins the complex, RNA-RNA rearrangements take place that result in U6 breaking 
away from U4 and replacing U1 at the 5’ splicing site, the exit of U1 and U4, the formation 
of the lariat structure, and cleavage at the 5’ site (Black, 2003; Staley and Guthrie, 1998). 
 These conformational changes create the spliceosome’s active catalytic sites and 
maneuver the pre-mRNA substrate into the appropriate position for the first of two 
phosphoryl-transferase reactions (Staley and Guthrie, 1998). In this first reaction, U6 binds to 
U2 and the unpaired adenine binds to the 5’ splice site. Additional RNA-RNA interactions 
now bring the two exons close together for the second phosphoryl-transferase reaction in 
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which cleavage occurs at the 3’ site, the intron lariat is released for degradation, and the two 
exons are joined (Black, 2003; Ruskin et al., 1984). 
 The existence of a splice site consensus sequence alone does not guarantee that the 
spliceosome will activate and carry out splicing. The most straightforward method of 
choosing sites is exon definition, in which components of the spliceosome (typically SR 
proteins) assemble along exons and serve as markers at each 5’ and 3’ splicing site, which 
recruits U1 snRNP and U2AF, triggering splicing of neighboring introns. In this case, both 
marking and recruitment are co-transcriptional but the actual splicing events can take place 
after transcription is complete. This approach is effective because the smaller and more 
uniform exons have more easily identified boundaries than introns, although it’s unclear how 
SR proteins are able to differentiate between the two. Enhancer sequences specific to these 
proteins may play a role (Black, 2003). 
 Other factors can also play a role in whether a potential splicing event takes place, as 
well as the specifics of how it is carried out. Many introns include more than one suitable 
splicing sequence, for instance, and any of these may be the one chosen. Regulatory 
sequences distinct from splicing sites can be found in both introns and exons and can 
function as enhancers that stimulate the spliceosome or silencers that repress its activity. 
Most of these sequences are protein binding sites but some function by forming secondary 
structures to expose or conceal a potential splice site. Little has been conclusively determined 
regarding the regulation of these potential factors and sequence data alone is not enough to 
predict activation of the spliceosome in response to a splicing site (Black, 2003; Matsui et al., 
1980).  
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 The structure and composition of the spliceosome is as highly conserved as the 
process of splicing itself, and a high degree of similarity between Drosophila and humans 
has been shown (Herold et al., 2009). Using mass spectrometry to analyze components of 
spliceosomal complexes, Herold and colleagues identified more than 120 proteins that are 
recruited to the spliceosome as snRNP subunits or that serve an accessory role to the process. 
The need for numerous subunit and accessory proteins is expected when considering the 
number of variable mechanisms used during splicing to render alternative isoforms, such as 
multiple 5’- or 3’-splice sites, selection of alternative exons, and the occasional retention of 
introns (Black, 2003).  
 The most dramatic example of the importance of alternative splicing in sensory 
neurons is the gene Dscam, a homolog of human DSCAM. Dendrites of individual md-da 
neurons do not cross paths, nor do dendrites of the same class; however, dendrites of 
different classes show significant overlap, which results in complete tiling of the body wall 
(Grueber et al., 2002). Mechanisms that control self-avoidance, type-avoidance, and tiling 
have been the subject of numerous studies (Jan and Jan, 2010). Dscam encodes a growth 
cone receptor in developing neurons that recognizes guidance signals and adjusts the 
cytoskeleton of the growing axon accordingly. Observed splicing patterns indicate more than 
38,000 possible isoforms yielding different proteins, which is more than double the total 
number of genes in the Drosophila genome (Schmucker et al., 2000). Additionally, the 
uniqueness of these isoforms plays an integral role in the self-avoidance necessary for proper 
dendrite morphology, forming cell-specific rather than type-specific identities. Expression 
patterns appear to be generated randomly and are dynamic; expression can adjust as needed 
to further reduce the risk of sharing isoforms with a nearby neuron (Miura et al., 2013).  
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Although the pattern a cell will express is apparently chosen at random, the assembly 
of that pattern is not. The Dscam gene has 115 exons. The 95 exons that are alternatively 
spliced are arranged in four clusters containing 12, 48, 33, and 2 variable exons. Any given 
transcript will have the ten exons that are not alternatively spliced and then a single exon 
from each cluster. This system of organized splicing variables is how the gene is able to 
produce so many unique isoforms (Park and Gravely, 2007). 
 Expression patterns of Dscam isoforms indicate the crucial role of alternative splicing 
in the ability of neurons to receive and transmit information, and md-da neurons rely on 
specific isoforms of other proteins as well. The para gene encodes proteins for voltage-gated 
sodium channels necessary for firing action potentials, which neurons require in order to 
transmit their signal. This gene has thirteen alternatively spliced sites (Park et al., 2004). 
 Para expression patterns appear to be developmentally regulated, given that eleven 
isoforms have been identified in embryos compared to eighteen found in adults, and 
expression rates for several exons shift up or down between embryonic and adult stages 
(Thackeray and Ganetzky, 1994). For instance, exon f was found present in more than 80% 
of embryonic clones and less than 7% of adult clones, suggesting there are functional 
differences in the resulting channels. This possibility is further supported by their 
identification of isoforms containing either exon c or d but not both. The specific differences 
in amino acid composition indicate a possible change in the voltage dependence of the gating 
between the isoforms, creating channels of varying sensitivity. 
 Isoforms of another highly conserved protein, Drosophila TRPA1, have also been 
found to serve crucial functions in md-da neurons (Zhong et al., 2012). Transient receptor 
potential (TRP) channels have a well-established role in numerous sensory systems. In their 
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study, Zhong and colleagues analyzed expression patterns of dTRPA1 in md-da neurons, as 
well as impact on the ability of Class IV neurons to serve their function as nociceptors, i.e. 
neurons responsible for detecting noxious stimuli in the environment and prompting an 
evasive response. The four isoforms evaluated were found to have variable temperature 
thresholds for heat activation, as well as variable responses to thermal vs. mechanical stimuli. 
Ability to perceive noxious stimuli (i.e. nociception) was highly dependent on appropriate 
isoform expression, providing yet another example of the necessity of alternative splicing for 
survival. 
 RNA processing plays a key role in shaping cell function. 5’ capping and 3’ 
polyadenylation are necessary for ensuring translation produces functional proteins by 
signaling intact transcripts. These modifications are also primary factors in controlling 
protein abundance within a cell. Alternative splicing determines which isoform is produced 
by transcription and, therefore, the specific function of proteins resulting from processed 
mRNA. As with the transcription process, understanding modification processes, how they 
are regulated, and the nature of the cell factors involved is a vital aspect of characterizing 
molecular pathways of interest. 
Mechanisms of Translation Initiation in Eukaryotic Cells 
 Like transcription and mRNA processing, translation of mRNA to functional proteins 
is fundamental to development of the gene expression profile that shapes the identity and 
function of any given cell type. Named for their roles in initiating translation, eukaryotic 
initiation factors (eIFs) guide the process and aid in protecting the integrity of resulting 
proteins. Although numerous accessory eIFs are involved, the primary factors are eIF4A, 
eIF4E, and eIF4G, which collectively form the eIF4F complex. As the rate-limiting step of 
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translation, initiation is an important focal point for regulation of protein production. 
Translation is regulated primarily by binding proteins that target eIF4F components, 
controlling activation and repression of these initiation factors (Gingras et al., 1999a). 
However, a variety of other mechanisms of regulation have been identified, the diversity of 
which reveal the complexity and versatility of translation control (Jackson et al., 2010). 
Characterizing the function and regulation of initiation factors is crucial for understanding 
the nuances of cell-specific gene expression. 
 eIF activity begins prior to translation as different factors bind to initiator tRNAs, 
mRNAs, and 40S ribosomal subunits, forming stable molecules ready for the interaction that 
initiates translation. Met-tRNAi
Met refers to the specific Methionine-bound initiator tRNA 
that binds to the AUG start codon during translation and includes a sequence recognized by 
initiation factors. When bound with GTP and eIF2, Met-tRNAi
Met forms a ternary complex 
ready for acceptance by the 40S subunit (Benne and Hershey, 1978). eIF1, eIF1A, and eIF3 
all combine with a 40S subunit, preventing premature binding with the 80S subunit and 
enabling acceptance of the Met-tRNAi
Met ternary complex to create the 43S complex (Hunter 
et al., 1977; Majumdar, 2003).  
 The eIF4F complex of three protein subunits interacts with mRNA molecules, 
activating them for translation (Benne and Hershey, 1978; Abramson et al., 1987). eIF4E 
binds to the 5’ 7-methylguanosine cap and eIF4G is a scaffold protein that recognizes the 
poly(A)-tail of the mRNA strand (Maroto and Sierra, 1989; Tarun and Sachs, 1996). The 
functions of these two subunits ensure that only intact mRNA molecules will be translated. 
The third subunit, eIF4A, is an RNA helicase that functions to unwind the secondary 
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structure of mRNA, enabling accessibility to the ribosome (Abramson et al., 1987; Dorn et 
al., 1993).  
The remaining steps of translation initiation can then take place. The eIF4F-bound 
mRNA, in conjunction with eIF4B, binds to the 43S complex to create the complete 43S 
preinitiation complex (Trachsel et al., 1977). The complex proceeds to scan the mRNA in 
search of an AUG codon flanked by nucleotide sequences that identify a start site for 
translation (Kozak, 1983). Recognition of the appropriate site requires eIF1 and eIF1A, 
which discriminate against non-AUG codons and unfavorable AUG codons (Pestova et al., 
1998; Pisarev et al., 2006). As the 43S complex binds at the chosen start site, conformational 
changes occur that displace eIF1 and allow eIF5-mediated hydrolysis of eIF2-bound GTP, 
forming the “closed” 48S initiation complex (Unbehaun et al., 2004). eIF5B can then mediate 
the process of joining the 60S ribosomal subunit, as well as releasing factors eIF-1, -3, -4B, -
4F, and -5 (Pestova et al., 2000; Unbehaun et al., 2004). In the final step of initiation, GTP 
hydrolysis by eIF5B enables its release (now GDP-bound) along with eIF1A (Pestova et al., 
2000). Initiation is then complete and the elongation-capable 80S ribosome can proceed with 
translation. 
 Initiation factors are well conserved across species. The genes encoding each of the 
eIFs described above have been identified in the genome of Drosophila and show a 
significant similarity to vertebrate orthologs, except eIF4B (Lasko, 2000); however, eIF4B in 
Drosophila has been characterized and was confirmed to function similarly to vertebrate 
orthologs. It does lack two features found in human EIF4B: the ability to interact with PABP 
and involvement with IRES-mediated translation (Hernandez et al., 2004b). 
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As a key component of translation function, eIFs are a common target for regulatory 
mechanisms of translation initiation. Regulating translation is a crucial component of a cell’s 
ability to adapt to changing conditions and developmental stages. Control of gene expression 
at this level (as opposed to transcription) allows for rapid yet reversible responses to maintain 
homeostasis, and targeting the rate-limiting step of initiation maximizes efficiency. The 
specificities of response necessary are situation-dependent. For instance, acute and transient 
changes to intracellular conditions require rapid responses that can reverse as soon as 
conditions have adjusted. On the other hand, shifting between developmental stages and 
associated expression profiles may call for responses that are rapid and then stabilize 
indefinitely as the new steady state. To accommodate a variety of situations that require a 
change in translation, several modes of interactions differing in specificity are employed in 
regulatory pathways.   
One mechanism for regulating translation is phosphorylation. For instance, translation 
initiation is inhibited when eIF2 or eIF2B subunits are phosphorylated by protein kinases. 
Given that these factors are necessary for effective cap-dependent translation, this 
nonspecific method results in global translation reduction throughout the cell. This 
translation repression mechanism is activated primarily as a reaction to stress that signals the 
need to conserve resources. Four identified eIF2 kinases function in response to specific 
situations: deprivation of heme in reticulocytes activates HRI; viral infection, heat, and UV 
radiation activate PKR; endoplasmic reticulum (ER) stress and/or accumulation of unfolded 
proteins activate PERK; and amino acid depletion activates GCN2 (Farrell et al., 1977; 
Harding et al., 2000; Proud, 2005).  
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When stress prompts a cell to shut down cap-dependent translation, non-translating 
mRNAs form an RNP complex called a stress granule (SG). mRNAs that were interrupted 
during the process of initiation are recruited to the SG, along with their bound initiation 
factors, 40S subunit, and poly(A)-binding protein. Numerous proteins and RNA-binding 
proteins that function in silencing, stabilizing, or metabolizing mRNA also join this complex. 
Displaced mRNAs are sorted and targeted for decay or stabilization. SGs disperse once the 
cell has recovered (Anderson and Kedersha, 2008).  
In Drosophila, heat shock induces changes in phosphorylation states of eIF4E 
(decreased) and eIF2α (increased), which is similar to effects observed in mammalian cells 
but to a much lesser degree. Nonetheless, notable stress response is apparent, manifesting as 
significant global repression of cap-dependent translation and simultaneous activation of 
preferential cap-independent translation of heat shock proteins (Anthony and Merrick, 1991; 
Duncan et al., 1995; Hernandez et al., 2004a). Additionally, phosphorylation of eIF2α in 
reaction to endoplasmic reticulum stress has been confirmed in Drosophila (Williams et al., 
2001), as well as the formation of stress granules that include the two Drosophila eIF2α 
kinases, GCN2 and PEK (Farny et al., 2009). 
 An alternative and less generalized role of phosphorylation is mediated by proteins 
that bind to eIF4E (4E-BPs). The Drosophila genome includes seven genes that encode 
eIF4E variants, three of which are alternatively spliced, as well as three genes encoding 4E-
BPs (Thor, cup, and mextli), all alternatively spliced (Attrill et al., 2016). Given multiple 
genes encoding different isoforms of both eIF4E and 4E-BPs, employing the latter as 
intermediaries allows for more selectivity by limiting the isoform(s) targeted (Hernandez et 
al., 2005). In an active state, 4E-BPs compete with eIF4G, phosphorylating any eIF4E 
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proteins to which they bind and rendering them inaccessible for binding with eIF4G, thereby 
preventing formation of the eIF4F complex (Mader et al., 1995). Translation can be 
upregulated in the cell by phosphorylation of 4E-BPs, rendering these proteins incapable of 
binding to eIF4E and freeing the initiation factor for binding with eIF4G (Gingras et al., 
1999b). Some mRNAs have a long and structured 5’ UTR, rendering them particularly 
dependent on eIF4E availability for translation and therefore highly regulated by mechanisms 
of translational control (Richter and Sonenberg, 2005). This is due to a second function of 
eIF4E, which is the stimulation of eIF4A helicase activity to unwind and restructure these 
more complicated 5’ UTRs. Increased availability of eIF4E is particularly important for 
translation of this pool of mRNAs (Feoktistova et al., 2013). 
Regulation of Initiation Factor Activity 
 RNA-binding proteins (RBPs) provide a highly selective means of regulating eIF 
activity due to specificity of binding sequences and are employed in a variety of mechanisms 
targeting different regions of mRNA. One potential albeit less common target region is the 5’ 
UTR. The most prominent example of regulation through 5’ UTR-protein interaction is iron 
regulatory protein (IRP), which inhibits translation of ferrin and eALAS mRNAs. Ferrin 
takes up excess iron from a cell for storage and eALAS uses iron for heme biosynthesis. 
When iron levels in a cell drop too low, IRP binds to a stem-loop structure in the 5’ region of 
both mRNAs known as the iron responsive element (IRE),.When IRP binds to IRE, the 
resulting structure allows binding of eIF4F but prevents recruitment of the 43S pre-initiation 
complex thereby preserving iron. Binding eIF4F may be for the purpose of quickly 
reinitiating translation of these mRNAs when iron levels rise  (Gray and Hentze, 1994; 
Muckenthaler et al., 1998). 
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Regulation via poly(A)-tail-protein interaction occurs via just one mechanism, which 
functions to stimulate translation rather than inhibiting the process. Poly(A)-binding protein 
(PABP) serves as a bridge between the mRNA tail and eIF4G bound to eIF4E at the 5’ cap, 
creating a circular loop of mRNA with both ends tethered to eIF4F. This interaction increases 
mRNA stability, reducing the risk of losing recruited eIF4F and subsequent need to compete 
for a replacement. PABP also enhances recruitment of ribosomal subunits, giving their bound 
mRNAs a significant advantage over mRNAs lacking PABP (Imataka et al., 1998; Kahvejian 
et al., 2005). A recent study has also identified other binding sites for PABP in addition to the 
poly(A)-tail, indicating the potential for involvement in numerous gene regulatory pathways 
and a greater diversity of function than previously supposed (Kini et al., 2016). 
The vast majority of identified RBP-mediated initiation control mechanisms function 
via 3’ UTR-protein interactions. The generic model of this interaction involves a protein 
specific to a binding site in the 3’ UTR of the target mRNA, a cap-binding protein, and a 
third bridging protein binding all three into a closed loop with the mRNA that prevents eIF4F 
from binding to the 5’ cap. This inactive form of mRNA must be derepressed before it can be 
activated for translation by eIF4F. The protein that binds to the 3’ UTR is the only one 
requiring recognition of a specific sequence so its identity depends on the target mRNA. The 
bridging and cap-binding proteins are more versatile and can function in more than one 
pathway. For example, the eIF4E-binding protein Cup in Drosophila (homologous to human 
4E-T) functions in two regulatory pathways that rely on 3’ UTR-protein interactions. In both 
pathways, Cup serves as the bridging protein. Its ability to bind with eIF4E and inactivate the 
initiation factor through phosphorylation provides the necessary cap-binding component. 
During oogenesis, Cup binds with recognition protein Bruno, which binds to a 3’ UTR 
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sequence on oskar transcripts, repressing translation until later stages (Nakamura et al., 
2004). During embryogenesis, Cup binds with Smaug, which is the recognition protein for 
repression of unlocalized nanos transcripts (Nelson et al., 2004). 
miRNAs also utilize the 3’ UTR, targeting their complementary mRNAs for 
repression and ultimately decay. When bound with Argonaute1 (Ago1), miRNAs form the 
RNA-induced silencing complex (RISC). Scaffolding protein GW182 is also recruited to the 
target mRNA. RISC silences mRNAs by forcing dissociation of eIF4A and preventing 
formation of the eIF4F complex necessary for translation. RISC inhibits eIF4A 
independently of GW182, but its recruitment enables the additional dissociation of eIF4E and 
subsequent deadenylation and decay of the silenced mRNA (Fukaya et al., 2014). miRNAs 
bind to the 3’ UTR of target mRNA through base pairing with complementary sequences, 
indicating the high degree of specificity intrinsic to this mechanism, although wobble base-
pairing can interfere to some degree. miRNA targets and effects on overall expression levels 
remain difficult to predict due to the large number of variables involved, e.g. relative levels 
of miRNA and mRNA, potential introduction of exogenous miRNA, factors specific to 
developmental stage or tissue type, etc. (Doench and Sharp, 2004). 
An additional mechanism has been identified in which decapping proteins involved in 
the mRNA degradation pathway also function in general repression of translation. Once 
translation is complete, exiting mRNAs accumulate into mRNPs with other mRNAs targeted 
for degradation. These mRNP aggregation locations within the cytoplasm are known as P 
bodies and are very similar to the stress granules described previously. Proteins functioning 
in the mRNA decay pathway are also present, including decapping activator proteins Dhh1p 
(S. cerevisiae; ortholog of human RCK/p54 and Drosophila Me31b) and Pat1p (S. cerevisiae; 
18 
ortholog of human Pat1b and Drosophila Patr-1). Each mRNA exiting translation is either 
targeted for decapping and degradation or recruited into the P body. Growth of P bodies is 
associated with increased global repression of translation, but it is unclear how individual 
mRNA fate is decided or how the size of the P body at any given time is determined. 
Additionally, Dhh1p, Rck/p54, and Me31b all play an active role in repression of translation. 
The repressive function of P bodies and associated decapping activators is in constant 
competition with that of translation machinery, each side keeping the other in check (Coller 
and Parker, 2005; Nakamura et al., 2001). 
 Regulation of translation initiation carries important implications for the nervous 
system. Due to the nature of neuroplasticity, the nervous system is particularly dependent on 
spatial and temporal control of gene expression. Translational control allows for the rapid 
and reversible changes necessary for all aspects of nervous system function (Costa-Mattioli 
et al., 2009). Nociceptor function is dependent on plasticity and therefore mediated by 
translation control (Woolf and Ma, 2007; Jimenez-Diaz et al., 2008). Elucidating these 
pathways is crucial to understanding how nociceptors function and improving methods for 
treatment of pain. It has also been established that intraneuronal differential translation 
control is a factor, i.e. regulation specific to the cell soma, dendrites, or axons rather than the 
cell as a whole (Price and Géranton, 2009). 
 In humans, Interleukin-6 (IL-6) and nerve growth factor (NGF) are primary mediators 
of acute and chronic pain, modulating translation by initiating signaling cascades along two 
different pathways. IL-6 signals travel the ERK/Mnk pathway and culminate in 
phosphorylation of eIF4E. NGF signals via the mTOR pathway to phosphorylate 4EBP and 
eIF4G. As described previously, phosphorylation of 4EBP renders it inactive and frees eIF4E 
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to bind with eIF4G, enabling formation of the eIF4F complex. Increased availability of 
eIF4E also preferentially increases translation of eIF4E-dependent mRNAs. Signals initiated 
by IL-6 and NGF converge from different pathways to activate all components of eIF4F and 
initiate translation in the axons of primary afferent neurons. Acute and chronic pain 
conditions are often associated with manifestation of symptoms at sites distal to ganglia, 
which is in accordance with the axonal expression resulting from initiation of translation by 
IL-6 and NGF signaling. Additionally, the mechanical sensitization observed depends on 
translation of mRNAs already present, confirming the role of translation control in 
nociceptive plasticity (Melemedjian et al., 2010). 
 An antagonistic mechanism to this sensitization functions in conjunction with 
neuronal P bodies, which have characteristics unique to sensory neurons. To decrease 
sensitivity, AMPK activators reduce mechanical allodynia induced by IL-6 and NGF and 
downregulate cap-dependent translation. Also, the translation inhibitors associated with P 
bodies increase formation whereas promoters of cap-dependent translation, such as those 
activated by IL-6 and NGF signaling, decrease P body formation. As a result, each 
mechanism regulating P body formation has an opposite effect on cap-dependent translation, 
suggesting a unique role for P bodies in the PNS and possibly nociceptive plasticity. This 
potential is further supported by previous studies of P body function in other cells of the PNS 
indicating association with and functions similar to BDNF, which has a known role in 
plasticity (Melemedjian et al., 2014). 
 Although there are no Drosophila orthologs of IL-6 or NGF, proteins and pathways 
analogous to those described above are present. IL-6 is a cytokine signaling protein that 
activates ERK/MnK, which is a JAK/STAT pathway. In Drosophila, Upd cytokines activate 
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Hopscotch/STAT92E, which is also a JAK/STAT pathway (Panayidou and Apidianakis, 
2013). The Drosophila neurotrophin Spätzle shares similarities with NGF (DeLotto and 
DeLotto, 1998). A TOR signaling pathway is also employed (Neufeld, 2004). Although no 
specific conclusions can be drawn based solely on similarities, the analogous proteins and 
signaling pathways found in Drosophila reinforce its usefulness as a model organism for 
nociception. 
 A recent study in mice confirmed that removal of 4E-BP1 also enhanced translation 
in the spinal cord and resulted in mechanical hypersensitivity. Additionally, these effects 
were due to increased translation of eIF4E-dependent mRNAs rather than general 
upregulation. Results also attributed the observed phenotype primarily to increased 
translation of neuroligin 1 (mouse; ortholog of human NLGN1 and Drosophila Nlg3). The 
mTOR/4E-BP/eIF4E pathway was again found to impact mechanical, but not thermal 
sensitivity (Khoutorsky et al., 2015). 
 The ability of cells to maintain homeostasis depends on rapid responses to changing 
conditions, which is most effectively achieved by altering gene expression without affecting 
levels of available mRNA. As with regulation of transcription and processing, regulating 
translation is a vital aspect of cell function and numerous mechanisms are employed with 
varying degrees of specificity. Additionally, the initiation factors that enable and control 
translation initiation are a prime target for regulation. Given that plasticity is inherent to 
neuron function, characterizing translational control mechanisms and targets is particularly 
vital to understanding nociception. eIF4E function has been revealed as more complex than 
previously determined and similar complexity of other initiation factors may yet be 
discovered. As our understanding improves regarding mechanisms transcription, mRNA 
21 
processing, and translation, the importance of regulation becomes clear. Understanding 
regulation necessitates the study of RNA-binding proteins. 
The Complex Roles of RNA-Binding Proteins in Regulating Gene Expression 
 Posttranscriptional regulation of gene expression is of particular importance within 
the nervous system, given its dependence on rapid response and plasticity for proper 
functioning. Processing (e.g. capping, splicing, and polyadenylation), transport/localization, 
translatability (e.g. repression vs. activation), and translation stages (initiation, elongation, 
and termination) of mRNA are all means of posttranscriptional regulation (Antic and Keene, 
1997). RBPs and ribonucleoprotein (RNP) complexes function in a variety of ways to 
mediate these regulatory processes (Burd and Dreyfuss, 1994). Posttranscriptional regulation 
is a component of many molecular pathways essential to development and maintenance, 
particularly within the nervous system. Identification and characterization of associated 
RBPs are necessary aspects of understanding how key pathways are regulated. Well 
conserved RNA-binding motifs are used to identify putative RBPs and gain clues to their 
function (Burd and Dreyfuss, 1994). Hundreds of putative RBPs annotated within the 
Drosophila genome are expressed in sensory neurons and relatively few have been well 
characterized. 
 One factor in neuronal plasticity is differential regulation of translation in different 
parts of the neuron (Price and Géranton, 2009). To enable rapid and specific responses, 
hundreds of mRNAs are transported through dendrites to synaptic sites (Davis et al., 1987; 
Moccia et al., 2003). RNA granules are also actively transported to and from dendrites in 
neurons. These complexes of mRNAs, RNPs, RBPs, ribosomal subunits, and decay enzymes 
have been identified as mobile centers for mRNA metabolism, including translation 
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(Knowles et al., 1996; Anderson and Kedersha, 2006), and RBPs mediate this localization 
(Zhang et al., 2001). Cytoplasmic polyadenylation element binding protein (CPEB) is known 
to mediate trafficking to dendrites and plays a role in activating translation as a synaptic 
response (Huang et al., 2002; Shin et al., 2004).  
The Drosophila homolog Orb has been found to function in similar roles during 
oogenesis (Weil, 2014), localizing mRNAs in conjunction with other proteins and activating 
translation during oogenesis (Johnstone and Lasko, 2001). Specifically, Orb functions to 
activate translation of osk and grk mRNA (Chang et al., 1999; Chang et al., 2001). 
Interestingly, one of Orb’s targets for activation is orb; to avoid ectopic expression, orb’s 
positive autoregulatory loop is repressed by another RBP, Cup, until the translation complex 
has localized properly (Wong and Schedl, 2011).  
Orb also functions within the nervous system, although its roles there have not been 
thoroughly explored. Knockdown of orb in mushroom body neurons prevents long term 
memory formation (Pai et al., 2013), and knockdown in class IV dendritic arborization (da) 
neurons results in abnormal dendrite branching patterns (Olesnicky et al., 2014). 
Pumilio Regulates Expression through Translation Repression 
Pumilio (Pum) is a well conserved translation repressor that exhibits diverse means of 
repression. Pum identifies RNA for repression primarily via an RNA-binding domain (RBD) 
of “Pum repeats” that binds to the 3’ UTR of target mRNA, regulating cap-dependent 
translation as well as cap-independent IRES-driven (Internal Ribosome Entry Site) 
translation (Wharton et al., 1998). Pum’s RBD antagonizes PABP function and recruits 
deadenylases to shorten the poly-A tail of the target mRNA, resulting in diminished 
translation and accelerating mRNA decay. Pum also associates with different context-
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dependent cofactors for repression (Weidmann et al., 2014). In addition to its conserved 
RBD, there are three domains in Pum’s N terminus that exhibit repressive activity 
(Weidmann et al., 2014). Pum is also capable of indirect repression, such as when targeting 
the transcription activator E2F. When Pum binds to the 3’ UTR of E2F3 mRNA, 
conformational changes occur that expose miRNA seed sequences, allow multiple miRNAs 
to bind to this region, and enhance repression of E2F3 translation, thereby reducing 
transcription of this activator’s downstream targets (Miles et al., 2012). Pum can function 
independently or in conjunction with other RBPs, most commonly Nanos (Nos). For 
example, Pum and Nos function as a protein complex to regulate expression throughout 
development and also in maintenance of germline stem cells (Parisi and Lin, 1999). 
 Pum serves numerous and diverse functions within the peripheral nervous system. In 
muscles, Pum is localized around neuromuscular junction (NMJ) boutons where the axons of 
motor neurons terminate at muscle cells, forming a synaptic cleft for signaling. Pum is 
expressed at type Ib and Is boutons, both of which contain glutamatergic synapses, Pum 
regulates morphology of the terminal for both Ib and Is boutons. Without Pum, Ib boutons 
are too few and too large relative to wild-type larvae, and restoring Pum in neurons 
(presynaptic) rescues the phenotype. Is boutons, on the other hand, increase in number, and 
restoring Pum in muscles (postsynaptic) rescues the phenotype. Also on the postsynaptic 
side, Pum represses unnecessary accumulation of eIF4E. Additionally, pumilio mutants 
exhibit an increased number of GluRIIa glutamate receptors and increased frequency of 
spontaneous release of neurotransmitter at the synapse (Menon et al., 2004). In sensory organ 
precursor (SOP) cells, Pum inhibits epidermal growth factor receptor (EGFR) signaling to 
prevent an excessive number of SOP cells and bristles from forming. In this case, Pum binds 
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to Nanos Response Element (NRE) sequences in the 3’ UTRs of numerous transcripts in the 
signaling pathway, including EGFR, Drk, Sos, and Rl (Kim et al., 2012). In class III and IV 
da neurons, Pum and Nos function together in dendrite morphogenesis. Mutants carrying loss 
of function alleles of pumilio or nanos exhibit abnormal higher-order dendrite branching 
patterns relative to wild-type larvae, and double mutants exhibit the same phenotype as each 
single mutant (Ye et al., 2004). Pum/Nos regulate normal dendrite density by repressing 
translation of head involution defective (hid), promoting branch extension and preventing 
branch retraction (i.e. promoting branch stabilization). Interestingly, this mechanism is 
dependent on an additional cofactor, Brain Tumor (Brat), and interaction with the eIF4E-like 
cap-binding protein d4EHP only in class IV da neurons. In class III da neurons, regulation of 
Hid expression and dendrite branching by Pum/Nos is not dependent on Brat/d4EHP 
(Olesnicky et al., 2012). 
 Additional regulatory mechanisms mediated by Pum have been identified in the 
central nervous system. Like Orb, Pum is also associated with RNA granules. When an event 
such as behavioral training triggers long-term memory formation, Staufen (RBP) mediates 
formation of neuronal RNA granules as well as transport of neuronal granules to synapses via 
dendrite microtubules. Pum (independent of Nos) represses mRNAs in transit to avoid 
ectopic expression. The granules release transported mRNAs at the synapse and local 
derepression of translation occurs, possibly activated by phosphorylation of Orb and/or 4E-
binding proteins (Dubnau et al., 2003). Pum also plays a role in homeostatic regulation of 
CNS neuron excitability via regulation of the voltage-gated Na+ channel encoded by 
paralytic (para). In response to elevated synaptic excitation, such as occurs during 
embryogenesis or remodeling that accompanies learning and memory formation, Pum binds 
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to para mRNA, reducing the level of transcripts available for translation and helping to 
maintain membrane excitability (Mee et al., 2004). Pum requires the cofactor Nos to function 
in this pathway; however, dependence on Brat is specific to cell type. Repression of para 
mRNA by Pum/Nos is Brat-dependent in some motoneurons but not in most CNS neurons. 
Pum also functions to downregulate Nos, which protects neurons from excessive repression 
of para mRNA if high levels of Pum are present (Muraro et al., 2008). Although, class IV da 
neurons (nociceptors) also rely on Para channels to fire action potentials, it cannot be 
assumed that Para activity is regulated in the same way due to the context-dependent nature 
of Pum repression. For instance, Nos’s repressive function is typically as a cofactor with 
Pum. On the postsynaptic side of the NMJ, however, Pum and Nos act in opposition to 
regulate glutamate receptor subunits (Menon et al., 2009). 
Elav Regulates Expression through Processing 
 Embryonic Lethal Abnormal Vision (elav) and its vertebrate homologs are expressed 
exclusively in neurons and are essential for development and maintenance of the nervous 
system. Expression occurs at greatest levels during early development once postmitotic 
neurons are present and continues at lower maintenance levels (Campos et al., 1985; 
Robinow and White, 1988). Elav functions primarily in mRNA processing. 
  One function of Elav is regulation of alternative splicing. The protein Neuroglian has 
two isoforms, one of which is specific to the nervous system and functions as a neural cell 
adhesion molecule important for neurite outgrowth, development of dendrites and axons, and 
plasticity (Hortsch et al., 1990). Elav binds to neuroglian pre-mRNA and regulates 
alternative splicing events that produce the neuron-specific isoform (Koushika et al., 1996; 
Lisbin et al., 2001), possibly by promoting readthrough of alternative splice sites as it does 
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with proximal poly(A) signals. Elav also regulates alternative splicing of neuron-specific 
isoforms of erect wind (ewg) and armadillo (arm); however, not all splicing events specific 
to neurons are regulated by Elav so study of individual events is necessary to determine how 
they are regulated (Koushika et al., 2000). Knockdown of elav in class IV da neurons causes 
abnormally short dendrite length and inadequate coverage of the larval body well, which may 
indicate that a splicing target of Elav is involved in dendrite morphogenesis (Olesnickey et 
al., 2014). 
 Elav also functions in alternative polyadenylation (APA), a process involving 
selection between multiple poly(A) signals within a gene during transcription resulting in 
different isoforms with altered 3’ UTRs. Since this region contains binding sites for RBPs 
and miRNAs, alterations affect how the transcripts can be regulated. Elav binds near 
proximal ploy(A) signals during transcription, resulting in readthrough of those signals and 
extension of 3’ UTRs enriched with regulatory binding sites. A strong preference for 
extended 3’ UTRs is apparent in the nervous system with hundreds of neuron-specific 
isoforms exhibiting this trait. RBPs and miRNAs are preferentially selected for 3’ UTR 
extension, indicating a highly complex system of regulation. Interestingly, some of the 
largest extensions are seen in highly active RBPs, such as orb (8.9 kb) and pumilio (10.1 kb), 
indicating the potential for auto- and cross-regulation (Hilgers et al., 2012; Smibert et al., 
2012). 
The discovery that Elav proteins are also present outside the nucleus in neuronal 
granules suggests some function in mRNA transport, stability and/or translation. mRNA 
decay is also a facet of regulation and AU-rich elements (AREs) in the 3’ UTR serve as a 
signal for rapid decay. When Elav binds to AREs, the degradation pathway is disrupted and 
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these mRNAs are stabilized (Gao et al., 1996; Keene, 1999; Brennan and Steitz, 2001). 
Additional roles for Elav aside from mRNA processing may yet be determined. 
Elav may regulate a given target via any or all of these mechanisms. Elav is involved 
in multiple regulation pathways of the Hox gene Ultrabithorax (Ubx). A study by Rogulja-
Ortmann et al. determined that Elav regulates alternative splicing and 3’ UTR extension of 
Ubx (2014). In addition to abnormal Ubx isoform expression in elav mutants, results 
indicated overall reduced expression levels. The authors suggested this could be due to 
degradation of improperly processed transcripts but did not report whether they evaluated the 
3’ UTR of Ubx mRNA for AREs. Reduced Ubx expression levels in elav mutants could 
indicate that Elav functions in stabilization of Ubx RNA in addition to processing. 
Regulation of Alternative Splicing 
 Numerous RBPs regulate alternative splicing. A recent study identified 56 diverse 
RBPs as splicing regulators, 12 of which had not been previously identified. Two of these, 
EIF3GA and Shep, had the 7th and 8th largest effect on splicing events. Both are expressed 
in the nervous system. Results also supported the multifunctional nature of RBPs. Cross-
regulation was observed as well with 26 of the RBPs being affected by another RBP on the 
list. In other words, 26 of the RBPs that function in splicing regulation result from transcripts 
that are alternatively spliced, and their expression levels are dependent on other splicing 
regulators. Additionally, each RBP was capable of either activating or repressing exons 
depending on the splicing event, and more than half of the splicing events were affected by 
more than one RBP (Brooks et al., 2015). 
 What is currently known regarding mechanisms that control alternative splicing is 
more general than specific. For instance, we know that competitive interaction between 
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trans-acting elements in binding to splicing enhancers or silencers is a factor in determining 
which exons are included in the resulting mRNA. The ultimate outcome of a splicing event 
can thus depend on variations and levels of specific splicing factors and regulators, all of 
which can be specific to genes, tissues, and/or developmental stage (Cáceres and Kornblihtt, 
2002).  
Contrasting the nature of splicing patterns between dTRPA1 (four isoforms with 
specific roles for md-da neuron function) and Dscam (over 38,000 isoforms capable of 
dynamic expression that are randomly generated from clusters of mutually exclusive 
alternative exons) demonstrates the likelihood that regulation is variable and dependent on 
context. The unique splicing patterns of Dscam likely involve unique methods of regulation. 
Celotto and Gravely explored possible means of regulation by examining expression of 
cluster 4 containing 12 mutually exclusive exons (2002). They found that regulation was to 
some degree dependent on development. Specifically, expression of 4.2 increased 
consistently across developmental stages, whereas exon 4.8 displayed an opposite trend. 
Alternative exons also exhibited tissue-dependent expression levels. 
 An excellent example of the gulf between general understanding and specific 
knowledge is a study by Brooks and colleagues in the Gravely laboratory regarding the role 
of Pasilla (PS), the Drosophila ortholog of human NOVA1 and NOVA2, a human protein 
known to regulate numerous splicing events. PS expression was reduced with interfering 
RNA (RNAi) in cultured cells and the resulting transcriptome was analyzed to identify 
changes in splicing events. 405 altered splicing events were identified, 19% of which 
included a previously unannotated splice junction. While results provided support for a 
regulatory role of PS in alternative splicing, they also raised additional questions. PS effects 
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could be either enhancing or silencing, rate of PS involvement was dependent on the specific 
mechanism involved (e.g. rarely in intron retention events), and many splicing events were 
completely unaffected (Brooks et al., 2011). When it comes to specific splicing events, 
general understanding provides some direction but little is known regarding the intricacies of 
associated molecular pathways. 
Taken together, the results from both studies reinforce the necessity to consider 
individual splicing events from multiple perspectives. Different RNA-binding proteins may 
regulate specific steps, tissue types, and/or developmental stages. The well-documented 
dependence on alternative splicing of the Drosophila sex determination pathway introduces 
yet another variable affecting regulation. In this pathway, the presence of two X 
chromosomes activates Sex-lethal (Sxl), a gene encoding an RBP that regulates splicing of 
another splicing regulator, TRA (Black, 2003). With regard to alternative splicing in md-da 
sensory neurons, the specifics of regulatory pathways remain largely unknown. 
Orb, Pumilio, Elav, and Pasilla all exhibit numerous roles in development and 
maintenance of the nervous system and employ diverse mechanisms of regulation. These are 
just four of hundreds of RBPs that function within neurons. Most have not yet been 
characterized. Due to the highly conserved nature of RNA-binding sites, however, putative 
RBPs have been identified. Given the significant impact of RBPs on neuron structure and 
function that has been established, a behavioral screen of RBPs expressed in class IV da 
neurons (nociceptors) should provide new direction for characterizing mechanisms of 
nociception. 
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Development of Screen for RNA-Processing Genes Regulating Nociception 
 With so many varied functions, it is likely that RBPs are regulating nociception in 
some way. An effective way to test a large number of potential genes of interest is to conduct 
a loss-of-function screen. With this method, RNAi strains are obtained for a pool of potential 
genes and used to test for changes in behavior when the function of a targeted gene is lost. 
These tests are conducted in relatively small sample sizes. Individual results can then be 
compared to population results to identify the strains worth the time required to test in high 
enough sample sizes to find statistically significant results. For our purposes, we wanted to 
develop a pool of genes for RBPs likely to affect nociception, obtain RNAi strains to knock 
down function, and use thermal nociception assays to test for either increased or decreased 
response time relative to wild-type larvae. 
To assemble our list of likely RBP candidates, we first considered RBPs with an 
established role in dendrite morphology. The Gavis laboratory at Princeton University 
conducted a broad screen of genes annotated as RNA-binding proteins or translation factors 
and identified 88 whose knockdown resulted in some type of abnormal dendrite morphology 
in the class IV neurons; Olesnicky et al., 2014). All of these proteins are involved in some 
type of post-transcription regulation, e.g. splicing regulation, translation control, etc. (Table 
1). The results of this research identified numerous implications of RNA processing for 
nervous system developmental pathways. The prevalent role of these proteins in nervous 
system function indicates a likelihood that at least some may regulate mRNA biogenesis of 
factors controlling nociception. The focus was on form rather than function, however, and 
behavioral assays were not included in this study. 
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A study by the Gravely laboratory at the University of Connecticut Health Center also 
supported the role of RNA-processing factors in nociception, focusing on genes purported to 
regulate alternative splicing (Park et al., 2004). They made mini-gene reporters of splicing 
events, added them to cultured Drosophila cells, and knocked down each predicted RNA-
binding protein. This generated a list of genes that code for RBPs with a confirmed impact on 
alternative splicing. All three genes studied are expressed in the nervous system. Any of the 
genes identified in this study could impact nociception but once again, behavioral assays 
were not performed.  
Combining the results from both studies yields a list of RNA-binding proteins with 
established function in sensory neurons that had not yet been studied on a behavioral level. It 
is reasonable, therefore, to evaluate them for function specifically in mdIV neurons by 
assessing impact on nocifensive response, which is the purpose of this RNAi screen to 
identify RNA-processing genes controlling nociceptor function. 
  
Molecular Function Number of Genes (%) 
Translation initiation 16 (18) 
Translation elongation 6 (7) 
Translation repression 5 (6) 
Translation termination and release 3 (3) 
mRNA splicing 17 (19) 
Cell death and engulfment 8 (9) 
Cytoskeleton 16 (18) 
Table 1: Molecular functions of genes controlling dendrite morphology 
(Olesnicky et al., 2014) 
32 
Materials and Methods 
 
Fly Strains 
Loss-of-function tests were performed using the GAL4/UAS system to knock down 
gene expression in Drosophila strains (Brand and Perrimon, 1993), crossing ppk-GAL4; 
UAS-dicer2 flies with transgenic RNAi lines for each of the 122 genes screened (Appendix 
A). GAL4 is a gene for a yeast transcription activator and UAS provides a binding site for 
GAL4, activating transcription of the downstream sequence. When ppk-GAL4; UAS-dicer2 
flies are crossed with UAS-RNAi flies targeting a specific gene, GAL4 drives transcription of 
that RNAi causing transcripts for the associated gene to be targeted for destruction. The ppk 
promoter was used to limit gene knockdown specifically to nociceptors, the only cells which 
express ppk (Zhong et al., 2010), thereby eliminating knockdown in other cells as a variable 
affecting any phenotype observed. Inclusion of dicer2 enhances the knockdown of RNAi 
(Dietzl et al., 2007). The following wild-type strains were used: y w; attP, VDRC isow, w1118, 
y v; attP2, y+ and y v; attP40, y+. When crossed with ppk-GAL4; UAS-dicer2 flies, no RNAi 
should be expressed, so these served as negative controls. A lab stock for para-RNAi was 
used as a positive control. 
Screening and Validation of RNAi Strains with Thermal Nociception Behavioral Assays 
 For each set of crosses, six ppk-GAL4; UAS-dicer2 virgin females and three males 
from an RNAi strain were added to vials containing food (Genesee Nutri-Fly prepared 
according to protocol in Appendix B), one vial per genotype, and kept in an incubator at 25 
°C and approximately 60-70% humidity. Each set also included one cross each for para 
RNAi males (positive control) and wild-type males corresponding to the background of 
RNAi strains tested (negative control). To reduce confounding variables, transgenic lines 
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were tested in groups according to genetic background with a wild-type strain of matching 
genetic background. All vials were anonymized for the purpose of blind testing and then 
given 48 hours to establish. The flies were flipped to new vials on the third day and again on 
the fourth in order to establish three sets of vials per cross for testing. 
Five to six days after initiation of vials, thermal nociception assays were performed 
on wandering 3rd instar larvae, the stage at which dendrites and sensory neuronal activity 
have fully developed (Zwart et al., 2013). For these assays, we created a probe by filing a flat 
side along the tip of a soldering iron. A thermocouple was attached to the tip with solder in 
order to constantly monitor temperature, and a voltage regulator was used to control the 
temperature. Assays were conducted at 46 ± 5 °C, which is above the heat threshold for 
normal nocifensive response (Tracey et al., 2003). Approximately 15-20 animals were gently 
washed from the vial with distilled water and added to a glass petri dish. Excess water was 
removed to prevent floating and accidental rolling, and larvae were kept moist enough to 
allow locomotion. Each trial was performed on a larva actively traveling in a straight path 
with enough surrounding clearance to prevent interference. The probe was applied laterally, 
flush with the larval body surface along abdominal segments A1-A3, and held in place until a 
full roll along the long body axis was observed or until at least ten seconds had elapsed. Each 
animal was tested once and then removed from the dish. Assays were performed on at least 
two different days with a minimum of 20 total trials for screen assays and a minimum of 50 
total trials for validation assays.  
Video Analysis 
To measure response latency, which is defined as the time in seconds (s) from 
initiation of contact to completion of nocifensive behavior (one full roll), I developed a 
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protocol for analyzing assay videos frame by frame using film editing software (Appendix 
C). This procedure allowed me to mark time points of contact and roll completion and 
quickly determine the time between markers. Any trial in which a larva failed to roll within 
10 seconds was recorded as 11 s and all trials were rounded to the nearest tenth. 
Statistics 
 Once the screen was completed, wild-type data were grouped by type for determining 
significant difference between types. The Kruskal-Wallis One Way ANOVA on Ranks was 
used and a significant difference was found (p < 0.001). Dunn’s Method for pairwise 
multiple comparisons was used to isolate differences. y v; attP2, y+ was different from every 
other group with p-values ranging from <0.001 to 0.036. For this reason, these data were 
considered separately to identify genes of interest. There were no other differences between 
groups found, so data for remaining four wild-type groups were analyzed as a single 
population. In each of the two groups, the cut-off for identifying genes of interest was one 
standard deviation above the population mean. 
 Three strains (eIF4A-RNAi, eIF2Bα-RNAi, and pumilio-RNAi) were validated in 
crosses testing one RNAi strain against one wild-type strain. For these, the Mann-Whitney 
Rank Sum Test was used to determine significant difference. All other genes validated were 
tested in crosses with more than one RNAi strain against one wild-type strain. eIF4E3-RNAi, 
eIF4G2-RNAi, and eIF4AIII-RNAi were all tested with y v; attP2, y+. eIF2α-RNAi, eIF3ga-
RNAi, and eIF1A-RNAi were all tested with y w; attP. The Kruskal-Wallis One Way 
ANOVA on Ranks was used to determine significant difference. Dunn’s Method for multiple 
comparisons versus control group was used to isolate differing groups. 
 SigmaPlot was used to run all tests (see Appendix D for complete output).   
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Results 
 
Proof-of-Principle Experiment to Establish para-RNAi as a Positive Control 
In order to demonstrate the effectiveness of the RNAi approach, an initial proof-of-
principle experiment was performed comparing ppk-GAL4; UAS-dicer2 females crossed with 
para-RNAi males and ppk-GAL4; UAS-dicer2 females crossed with isoW wild-type males. 
ppk was used as a promoter to ensure nociceptor-specific knockdown. Thermal nociception 
assays were performed on wandering 3rd instar larvae at 46°C. Assays were performed on 
two different days with more than 50 total trials for each cross.  
para is a protein-coding gene that encodes a subunit of the voltage-gated Na+ 
channels required for neurons to fire action potentials (Ganetzky and Wu, 1986). If gene 
knockdown with RNAi is effective, larvae with para RNAi expressed in nociceptors are 
predicted to exhibit significantly increased latency in nocifensive response, indicating a 
decrease in sensitivity of the nociceptor neurons (Thackeray and Ganetzky, 1994). The 
results from my initial experiment were as expected: none of the para-RNAi larvae responded 
Figure 1: Thermal nociception response latency confirms a nociception defect in para-RNAi 
larvae. isoW (wild type) larvae had a mean response time of 2.43 s (n = 50). para-RNAi 
larvae had a mean response time of 11 s (n = 50). Error bars show standard deviation. 
36 
within ten seconds (Fig. 1). A para-RNAi cross was subsequently used as the positive control 
for each set of experimental crosses. 
Insensitivity Screen of RNA-Processing Genes to Identify Potential Genes of Interest 
 Repeating the above procedure with the ppk promoter to limit RNAi expression to 
nociceptors, a total of 122 RNAi strains targeting RNA-processing genes were screened 
using thermal nociception assays at 46°C. Response latency was measured; an increased 
response time for RNAi larvae relative to wild-type larvae indicates an insensitivity 
phenotype and potential nociception defect. The RNAi strains that we obtained were created 
in five different wild-type backgrounds, which necessitated evaluation for differences 
between wild types. Once the screen was completed, response latency for all wild-type data 
were compared and statistical tests determined that the data for y v; attP2, y+ larvae were 
significantly different from the data for all other wild types. There were no significant 
differences in response latency among the other four wild types (Appendix D). For this 
reason, results were separated accordingly into two groups for further analysis. In both 
analysis groups, one standard deviation above the population mean was used as the threshold 
for identifying potential genes of interest for additional testing (Figs. 2-4). Between the two 
analysis groups, a total of 23 such genes were identified.  
 
37 
  
F
ig
u
re
 2
: 
M
ea
n
 n
o
ci
fe
n
si
v
e 
re
sp
o
n
se
 l
at
en
c
y
 i
n
d
ic
at
es
 s
ix
 p
o
te
n
ti
al
 c
an
d
id
at
e 
g
en
es
 
R
N
A
i 
st
ra
in
s 
w
it
h
 y
 v
; 
a
tt
P
2
, 
y+
 g
en
et
ic
 b
ac
k
g
ro
u
n
d
. 
H
o
ri
zo
n
ta
l 
li
n
e 
in
d
ic
at
es
 o
n
e 
st
an
d
ar
d
 d
ev
ia
ti
o
n
 a
b
o
v
e 
th
e 
p
o
p
u
la
ti
o
n
 m
ea
n
 o
f 
2
.5
7
 s
, 
th
e 
cu
t-
o
ff
 t
o
 i
d
en
ti
fy
 g
en
es
 o
f 
in
te
re
st
 (
sh
ad
ed
 a
re
a)
. 
E
rr
o
r 
b
ar
s 
sh
o
w
 s
ta
n
d
ar
d
 d
ev
ia
ti
o
n
. 
N
 >
 2
0
 f
o
r 
ea
ch
 s
tr
ai
n
 t
es
te
d
. 
C
o
n
tr
o
ls
 i
n
 b
la
ck
. 
38 
  
F
ig
u
re
 3
: 
M
ea
n
 n
o
ci
fe
n
si
v
e 
re
sp
o
n
se
 l
at
en
c
y
 i
n
d
ic
at
es
 1
5
 p
o
te
n
ti
al
 c
an
d
id
at
e 
g
en
es
 
R
N
A
i 
st
ra
in
s 
w
it
h
 y
 w
; 
a
tt
P
 g
en
et
ic
 b
ac
k
g
ro
u
n
d
. 
A
n
al
y
ze
d
 a
s 
a 
p
o
p
u
la
ti
o
n
 w
it
h
 s
tr
ai
n
s 
w
it
h
 i
so
W
, 
W
1
1
1
8
, 
an
d
 y
 v
; 
a
tt
P
4
0
, 
y+
 
b
ac
k
g
ro
u
n
d
 s
tr
ai
n
s.
 H
o
ri
zo
n
ta
l 
li
n
e 
in
d
ic
at
es
 o
n
e 
st
an
d
ar
d
 d
ev
ia
ti
o
n
 a
b
o
v
e 
th
e 
p
o
p
u
la
ti
o
n
 m
ea
n
 o
f 
3
.6
8
 s
, 
th
e 
cu
t-
o
ff
 t
o
 i
d
en
ti
fy
 
g
en
es
 o
f 
in
te
re
st
 (
sh
ad
ed
 a
re
a)
. 
E
rr
o
r 
b
ar
s 
sh
o
w
 s
ta
n
d
ar
d
 d
ev
ia
ti
o
n
. 
N
 >
 2
0
 f
o
r 
ea
ch
 s
tr
ai
n
 t
es
te
d
. 
C
o
n
tr
o
ls
 i
n
 b
la
ck
. 
39 
  
F
ig
u
re
 4
: 
M
ea
n
 n
o
ci
fe
n
si
v
e 
re
sp
o
n
se
 l
at
en
c
y
 i
n
d
ic
at
es
 t
w
o
 p
o
te
n
ti
al
 c
an
d
id
at
e 
g
en
es
 
R
N
A
i 
st
ra
in
s 
w
it
h
 i
so
W
, 
W
1
1
1
8
, 
an
d
 y
 v
; 
a
tt
P
4
0
, 
y+
 g
en
et
ic
 b
ac
k
g
ro
u
n
d
s.
 A
n
al
y
ze
d
 a
s 
a 
p
o
p
u
la
ti
o
n
 w
it
h
 s
tr
ai
n
s 
w
it
h
 y
 w
; 
a
tt
P
 
b
ac
k
g
ro
u
n
d
 s
tr
ai
n
s.
 H
o
ri
zo
n
ta
l 
li
n
e 
in
d
ic
at
es
 o
n
e 
st
an
d
ar
d
 d
ev
ia
ti
o
n
 a
b
o
v
e 
th
e 
p
o
p
u
la
ti
o
n
 m
ea
n
 o
f 
3
.6
8
 s
, 
th
e 
cu
t-
o
ff
 t
o
 i
d
en
ti
fy
 
g
en
es
 o
f 
in
te
re
st
 (
sh
ad
ed
 a
re
a)
. 
E
rr
o
r 
b
ar
s 
sh
o
w
 s
ta
n
d
ar
d
 d
ev
ia
ti
o
n
. 
N
 >
 2
0
 f
o
r 
ea
ch
 s
tr
ai
n
 t
es
te
d
. 
C
o
n
tr
o
ls
 i
n
 b
la
ck
. 
 
40 
Table 2: Identified genes of interest with orthologs 
(y v; attP2, y+ background strains) 
In the analysis group with y v; attP2, y+ wild-type background, six genes were 
identified with average response latencies ranging from 3.12 to 5.31 s, compared to wild-type 
response latency of 2.40 s (Table 2, Fig. 5).  
 
 
 
 
CG # Name Mean NEL (s) N Human Ortholog(s) 
CG8023 eIF4E3 3.12 34 EIF4E, EIF4E1B 
CG4262 elav 3.43 41 ELAVL4, ELAVL2, ELAVL3, ELAVL1 
CG12413 mIF2 3.47 28 MTIF2 
CG1691 imp 3.76 43 IGF2BP1, IGF2BP3, IGF2BP2 
CG10192 eIF4G2 5.05 33 EIF4G3, EIF4G1 
CG7483 eIF4AIII 5.31 35 EIF4A3 
 
  
Figure 5: Thermal nociception response latency for identified candidate genes 
RNAi strains with y v; attP2, y+ genetic background. Boxes show 1st quartile, 
median, and 3rd quartile. Whiskers show minimum and maximum. Diamonds show 
means. Shaded box is negative control. Horizontal lines are one and two standard 
deviations above population mean of 2.57 s. N > 20 
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The remaining strains were evaluated as a second group and included TRiP RNAi 
lines in y v; attP40, y+ wild-type background, VDRC RNAi lines in yw;attP and isoW wild-
type backgrounds, and NIG RNAi lines in W1118 wild-type background. In this analysis 
group, seventeen genes were identified with average response latencies ranging from 4.76 to 
8.05 s, compared to wild-type average response latencies ranging from 3.02 to 3.57 s (Table 
3, Fig. 6).  
CG # Name Mean NEL (s) N Human Ortholog(s) 
CG4119 CG4119 4.76 37 RBM25 
CG6197 fandango 4.99 25 XAB2 
CG32706 CG32706 5.07 30 ABT1 
CG8053 eIF1A 5.18 29 EIF1AY, EIFIAX 
CG13425 bancal 5.21 45 HNRNPK 
CG31762 bruno 1 5.27 24 CELF2, CELF1 
CG8730 drosha 5.34 35 DROSHA 
CG4396 fne 5.39 33 ELAVL4, ELAVL2, ELAVL3, ELAVL1 
CG11505 CG11505 5.67 41 LARP4, LARP4B 
CG8636 eIF3ga 5.80 38 EIF3G 
CG7185 CG7185 5.83 30 CPSF6, CPSF7 
CG10445 CG10445 5.85 21 TTF2 
CG9946 eIF2α 6.24 45 EIF2S1 
CG4528 sans fille 6.33 23 SNRPA, SNRPB2 
CG33197 muscleblind 6.73 49 MBNL2, MBNL1, MBNL3 
CG5442 SC35 7.10 47 SRSF2 
CG9075 eIF4A 8.05 23 EIF4A2, EIF4A1 
 
  
Table 3: Identified genes of interest with orthologs 
(y w; attP, isoW, W1118, and y v; attP40, y+ background strains) 
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In both analysis groups, a range of outcomes was observed when knocking down 
different translation initiation factors (Fig. 7). Fourteen factors exhibited normal behavior 
(response latency within one standard deviation of the population mean), while eight 
exhibited an insensitive nociception defection (response latency one to two standard 
deviations above the mean). I found this variation interesting and selected a number of these 
genes for further testing to validate the insensitive phenotype indicated by the screen. 
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Figure 7: Thermal nociception response latency for initiation factors  
Top: y v, attP2, y+ background strains, population mean 2.57 s.  
Bottom: y w; attP, isoW, W1118, and y v; attP40, y+ background strains,  
population mean 3.68 s 
Boxes show 1st quartile, median, and 3rd quartile. Whiskers show minimum and maximum. 
Diamonds show means. Shaded box is negative control. Horizontal lines are one and two 
standard deviations above population mean. N > 20 
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Validation of Insensitive Nociception Phenotypes 
 As previously discussed, the purpose of a screen is to make efficient use of time and 
resources by narrowing a large pool of potential genes of interest to a small group of the most 
promising genes. The small sample sizes preclude statistical analysis and can produce false 
positives; however, the results are useful for narrowing research focus to the most likely 
candidates. Further testing is required to statistically confirm a phenotype.  
For validation purposes, the steps of the screening process were repeated but with a 
minimum of fifty trials. Crosses were once again grouped according to genetic background 
with the associated wild type as negative control and para-RNAi as positive control. For all 
validation crosses, para-RNAi larvae performed as expected with an average response latency 
of 11 seconds. Non-parametric statistical tests were performed on each data set due to the 
lack of normal distribution. 
 An insensitive nociception phenotype 
was confirmed for seven genes. eIF4A-RNAi 
was tested with negative control VDRC isoW 
(n = 77 and 79, respectively) (Fig. 8). The 
response latency of eIF4A-RNAi (6.16 s mean) 
was significantly greater than the response 
latency of isoW (2.87 s mean), p < 0.001.  
Figure 8: Thermal nociception response latency validates eIF4A-RNAi insensitive phenotype  
Boxes show 1st quartile, median, and 3rd quartile. Whiskers show minimum and maximum. 
Diamonds show means. Shaded box is negative control.  
isoW mean latency is 2.87, n = 77.  
eIF4A-RNAi mean latency is 6.16 s, n = 79.  
***Significant difference (p < 0.001) 
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eIF4E3, eIF4G2, and eIF4AIII RNAi were tested with negative control y v; attp2, y+ 
(n = 55, 52, 54 and 58, respectively) (Fig. 9). The response latencies of eIF4E3-RNAi      
(3.58 s mean), eIF4G2-RNAi (3.64 s mean), and eIF4AIII-RNAi (4.65 s mean) were all 
significantly greater than the response latency of y v; attP2, y+ (2.65 s mean), p = 0.005, p = 
0.04, and p < 0.001, respectively.  
  
Figure 9: Thermal nocifensive response latency validates insensitive phenotype for 
eIF4E3, eIF4G2, and eIF4AIII RNAi 
Boxes show 1st quartile, median, and 3rd quartile. Whiskers show minimum and maximum.  
Diamonds show means. Shaded box is negative control.  
y v; attP2, y+ mean latency is 2.65, n = 58. 
eIF4E3-RNAi mean latency is 3.58 s, n = 52. **Significant difference (p = 0.005). 
eIF4G2-RNAi mean latency is 3.64 s, n = 55. *Significant difference (p = 0.040). 
eIF4AIII-RNAi mean latency is 4.65 s, n = 54. ***Significant difference (p < 0.001) 
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eIF2α, eIF3ga, and eIF1A RNAi were tested with negative control y w; attp (n = 63, 
66, 63 and 61, respectively) (Fig. 10). The response latencies of eIF2α-RNAi (4.76 s mean), 
eIF3ga-RNAi (4.80 s mean), and eIF1A-RNAi (8.22 s mean) were all significantly greater 
than the response latency of yw; attp (2.95 s mean), p < 0.001 for each of the three 
comparisons.  
  
Figure 10: Thermal nocifensive response latency validates insensitive phenotype for 
eIF2α, eIF3ga, and eIF1A RNAi  
Boxes show 1st quartile, median, and 3rd quartile. Whiskers show minimum and maximum. 
Diamonds show means. Shaded box is negative control.  
y w; attP mean latency is 2.95, n = 61. 
eIF2α-RNAi mean latency is 4.76 s, n = 63. ***Significant difference (p < 0.001). 
eIF3ga-RNAi mean latency is 4.80 s, n = 66. ***Significant difference (p < 0.001). 
eIF1A-RNAi mean latency is 8.22 s, n = 63. ***Significant difference (p < 0.001) 
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Identification and Validation of Hypersensitive Nociception Phenotypes 
 A number of genes screened had response latencies at or below wild-type, but the 
response rate at 46°C is too rapid to accurately discern if mutants are truly responding more 
quickly. A second complete screen was beyond the scope of this project, but we were curious 
to see if we could develop a procedure for identifying hypersensitive nociception phenotypes. 
To this end, a “mini screen” for hypersensitivity was conducted for a number of genes with 
the probe adjusted to 42°C. Since only about half of wild-type larvae respond at this 
temperature, we had a broader range of response rate to compare with mutants. These tests 
were limited to one day and only 10-15 trials, so the results are not useful for eliminating 
genes from consideration for a potential phenotype; however, two genes, eIF2Bα and pumilio 
(pum), were identified as potential candidates and validation testing was done in order to 
confirm the usefulness of screening at 42°C. 
 eIF2Bα-RNAi was tested with negative control y v; attP40, y+ (n = 61 and 51, 
respectively) (Fig. 11). The response latency of eIF2Bα-RNAi (7.92 s mean) was significantly 
lower than the average response latency of y v; attP40, y+ (9.43 s mean), p = 0.001. 
pum-RNAi was tested with negative control y v; attP2, y+ (n = 51 and 45, 
respectively) (Fig. 12). The response latency of pum-RNAi (5.21 s mean) was significantly 
lower than the average response latency of y v; attP2, y+ (6.58 s mean), p = 0.034.  
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Figure 11: Thermal nocifensive response 
latency validates eIF2Bα-RNAi 
hypersensitive phenotype 
Boxes show 1st quartile, median, and 3rd 
quartile. Whiskers show minimum and 
maximum. Diamonds show means.  
Shaded box is negative control.  
y v; attP40, y+ mean latency is 9.43 s,  
n = 51.   
eIF2Bα-RNAi mean latency is 7.92 s,  
n = 61. 
 ***Significant difference (p = 0.001) 
Figure 12: Thermal nocifensive response 
latency validates pumilio-RNAi 
hypersensitive phenotype 
Boxes show 1st quartile, median, and 3rd 
quartile. Whiskers show minimum and 
maximum. Diamonds show means.  
Shaded box is negative control.  
y v; attP2, y+ mean latency is 6.58, 
 n = 45.  
pumilio-RNAi mean latency is 5.21 s,  
n = 51. 
 *Significant difference (p = 0.034) 
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Lack of correlation between defects in dendrite morphology and nocifensive response 
Many of the genes included in this screen were chosen due to confirmed phenotypes 
for morphological defects in mdIV dendrites, which allowed us to evaluate for a correlation 
between presence/severity of dendrite defect and nocifensive behavior. When compared with 
results found by the Gavis lab regarding RNA-binding proteins and dendrite development in 
nociceptors (Olesnicky et al., 2014), the results from this screen indicate that abnormal 
dendrite morphology will not necessarily cause a defect in nocifensive response. Knocking 
down function of some genes caused a defect in dendrite patterning but not nocifensive 
response; the reverse is also true. 
A wide variety of morphological defects were observed by the Gavis lab and these are 
included in the table below (Table 4). “Reduction in field coverage” refers to defects that 
result in a failure of dendrites to evenly cover the larval body wall. In this case, number of 
branch points and branch length may be normal, but the dendrites fail to spread out evenly to 
achieve normal coverage. Other defects include too many or too few branch points along the 
dendrites and either an increase or decrease in overall branch length. We found no correlation 
between the type or severity of morphological defect and nocifensive response.  
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Table 4: Dendrite morphology phenotypes in candidate nociception genes 
CG# Gene Name 
Nociception Defect 
Identified by Bellemer Lab 
Dendrite Defect 
Identified by Gavis lab 
CG8053 eIF1A 
Y 
Y; severe reduction in 
field coverage 
CG9946 eIF2α 
CG8636 eIF3ga 
CG4153 eIF2β 
N 
CG6779 RpS3 
CG8882 eIF3i 
CG9769 eIF3f1 
CG4878 eIF3b 
CG9075 eIF4A Y 
Y; less severe 
reduction in field 
coverage 
CG9124 eIF3h 
N CG7883 eIF2Bα 
CG10124 eIF4E4 
CG4262 elav 
Y 
Y; increase in branch 
number and/or density 
CG33197 muscleblind 
CG4528 sans fille 
CG10203 x16 
N CG3582 U2af38 
CG10868 orb 
CG31762 bruno1 Y 
Y; decreased length 
due to branch loss 
CG18259   
N 
CG4792 dicer1 
CG11334   
CG6539 Gemin3 
CG9054 Dead-box-1 
CG17492 mind bomb 2 
CG16901 squid 
CG14718   
CG4602 Srp54 
N 
Y; branch points 
reduced 
CG6866 loquacious 
CG17686 DIP1 
CG6418   
CG5705   
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Table 4 (continued) 
CG# Gene Name 
Nociception Defect 
Identified by Bellemer Lab 
Dendrite Defect 
Identified by Gavis lab 
CG13425 bancal 
Y Y; unspecified 
CG11505   
CG32706   
CG4119   
CG8730 drosha 
CG4396 fne 
CG12413 mIF2  
Y None found 
CG7185   
CG7483 eIF4AIII 
CG8023 eIF4E3 
CG10192 eIF4G2 
CG1691 imp 
CG5442 SC35 
CG10445   
Y not tested 
CG6197 fandango 
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Lack of correlation between splicing defects and nocifensive response 
 Alternative splicing is a crucial factor in nociception. As one example, functionality is 
dependent on appropriate expression of TrpA1 isoforms. For this reason, we also included 
many genes in this screen that are expressed in neurons and have a confirmed role in 
alternative splicing. RBPs that are known to regulate splicing events that occur in neurons, 
such as modification of Dscam and para transcripts, could be regulating splicing events 
important to nociception, such as those that occur in TrpA1 transcripts.  
There was no correlation between this screen’s results and effects on splicing targets 
observed by the Gravely lab (Park et al., 2004). For genes affecting splicing of Dscam exon 
4, para exons A/I, and dAdar exons 3/3a, at least one but not all exhibited a nociception 
defect. None of the genes affecting Dscam exon 17 splicing nor the gene affecting splicing of 
para exons O/N exhibited a nociception defect. This lack of correlation suggests that effects 
on these splicing targets alone are not enough to explain the observed nociception defects. 
RBPs encoded by these genes may impact other splicing events necessary for nociceptor 
function or a different regulatory role may be responsible. 
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Table 5: Splicing regulation in candidate nociception genes  
Identified candidate genes with potential defect in bold 
Dscam exon 4  para exons A/I 
CG# Gene Name  CG6197 fandango 
CG6197 fandango  CG9075 eIF4A 
CG4528 snf  CG10445   
CG5442 SC35  CG5728   
CG7185    CG8144 ps 
CG13425 bancal  CG10293 how 
CG31762 aret  CG10418   
CG2926    CG11360   
CG3582 U2af38  CG12759 Dbp45A 
CG42320 Doa  CG12924 Lsm11 
CG4602 Srp54    
CG5422 Rox8  dAdar exon 3/3a 
CG5931 l(3)72Ab  CG4119   
CG6227 Prp5  CG3193 crn 
CG6841 Prp6  CG5422 Rox8 
CG6995 Saf-B  CG5454 snRNP-U1-C 
CG6999    CG8749 snRNP-U1-70K 
CG7269 Hel25E  CG10851 B52 
CG7437 mub  CG12085 pUf68 
CG8019 hay    
CG8144 ps  Dscam exon 17 
CG8241 pea  CG# Gene Name 
CG9696 dom  CG4602 Srp54 
CG9998 U2af50  CG5931 l(3)72Ab 
CG10210 tst  CG6999   
CG10279 Rm62  CG7269 Hel25E 
CG10293 how  CG10279 Rm62 
CG10851 B52  CG11266 Caper 
CG11266 caper  CG12085 pUf68 
CG11360    CG42320 Doa 
CG12085 pUf68    
CG12749 Hrb87F  para exons O/N 
CG14641    CG8144 Ps 
CG16901 squid    
CG16941 SF3a1    
CG17454      
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Discussion 
 
 Out of 122 genes tested in this screen, 25 (20.5%) were identified as potential genes 
of interest that had not previously been identified as affecting nocifensive behavior. Nine of 
these were subsequently validated (7.4% of all genes studied). Although there is an 
expectation that not all hits will be confirmed, none have been invalidated thus far. These 
results affirm the effectiveness of the screening approach. Screen results are particularly 
useful when they can be compared and contrasted with data from research on other aspects of 
the same mechanistic pathway. Confirming the lack of correlation between nocifensive 
behavior and dendrite morphology or specific splicing events is very useful knowledge. After 
all, it is the perception of pain that we seek to address with clinical intervention. 
Coordinating morphological, molecular, and behavioral studies in Drosophila will contribute 
to a more comprehensive understanding of pain mechanisms. For instance, although all seven 
genes with a validated insensitive phenotype are initiation factors, there is a surprising level 
of complexity to their potential mechanisms of regulation.  
Initiation Factors with Insensitive Phenotype: Regulation via Translational Control 
 Six genes confirmed to have an insensitive phenotype are translation initiation 
factors: eIF1A, eIF2α, eIF3ga, eIF4A, eIF4E3, and eIF4G2. Given the dependence of 
nociceptor function and sensitivity on differential protein synthesis in the cell body, 
dendrites, and axons (Price and Géranton, 2009), these results may indicate the specific genes 
involved in translational control necessary for nocieptor sensitivity.  
As previously discussed, the eIF4F translation initiation complex includes the 
subunits eIF4A, eIF4E, and eIF4G. The Drosophila gene eIF4G encodes the 4G subunit for 
this complex. Two other genes, eIF4G2 and NAT1, encode proteins highly similar to eIF4G. 
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eIF4G2 has been established as a homolog of eIF4G (Franklin-Dumont et al., 2007), whereas 
NAT1 lacks the eIF4E binding site and plays a role in translation suppression (Imataka et al., 
1997). All three genes were tested in this screen and only eIF4G2 displayed an insensitive 
phenotype. Seven Drosophila genes encode isoforms of the 4E subunit (Hernandez et al., 
2005), four of which had RNAi lines available for this screen. Of those four, eIF4E3 was the 
only gene to display an insensitive phenotype.   
The specific 4E and 4G subunits identified in this screen are non-canonical. eIF4G2 
has been established as a homolog of eIF4G and its necessity in some translation processes 
has been confirmed (Baker and Fuller, 2007), but its verified role in translation has been 
considered somewhat puzzling because it lacks the domain necessary to bind eIF5 (Ghosh 
and Lasko, 2015). eIF4E3 also differs from the canonical 4E subunit, lacking both the high 
affinity for eIF4G found with eIF4E-1/2 and eIF4E-4 (Hernandez et al., 2005). 4E subunit 
activity is normally regulated via a serine residue that can be phosphorylated (Scheper and 
Proud, 2002) or sequences allowing for interaction with 4E-BPs, as previously discussed. 
eIF4E3 lacks both of these regulatory features (Hernandez et al., 2012). 
If eIF4G2 and eIF4E3 function as 4G and 4E subunits integral to translational control 
of nociceptor sensitivity, they could be potential targets for clinical intervention in patients 
with chronic pain conditions due to the high degree of function similarity between human 
and Drosophila subunits (Grüner et al., 2016). Interaction between eIF4G2 and eIF4E3 has 
been established in the testis and eIF4G2 was found to colocalize in the testis to a 
significantly greater degree with 4E3 than did eIF4G. Additionally, a variety of eIF4F 
complexes with differing 4G and 4E subunit combinations are involved in spermatogenesis, 
suggesting a potential mode of translational control involving mRNA-specific 4F complexes 
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(Hernandez et al., 2012; Ghosh and Lasko, 2015). It is possible that eIF4E3 and eIF4G2 
function similarly in md-da neurons to create an eIF4F complex specific to nocifensive 
response. Isoform-specific functions have been observed in human eIF4G and eIF4GII as 
well (Pyronnet et al., 2001). 
Initiation Factors with Insensitive Phenotype: Regulation via Alternative Splicing 
The importance of translational control to nociceptor function is well established; 
however, it must be considered that one or more eIFs may affect nociception via regulatory 
targets other than translation initiation. This is particularly true for eIF4AIII, the only 
“eukaryotic initiation factor” (eIF) identified by this screen that is not actually involved with 
translation initiation. Although eIF4AIII is named for its sequential similarity to eIF4A, its 
length is only 1656 base pairs compared to eIF4A’s length of 4145 base pairs, it is not 
redundant for eIF4A (Lasko, 2000), and translation initiation activity has not been observed.  
eIF4AIII does serve important functions, however, such as its role in alternative 
splicing as a core component of the exon junction complex (EJC) (Tange et al., 2004). For 
instance, eIF4AIII is required for MAP kinase splicing and expression and ultimately, 
function of the RAS/MAPK signaling pathway (Roignant and Treisman, 2010; Ashton-
Beaucage et al., 2010). Knockdown of eIF4AIII expression has been shown to reduce 
neuronal hyperexcitability in seizure mutants, which correlates with the insensitive 
phenotype validated here; however, pasilla RNAi produced similar results in seizure mutants 
yet did not display an insensitive phenotype in this screen (Lin et al., 2015). Therefore, 
eIF4AIII may be involved in regulating alternative splicing of other genes important for 
nociception function. Involvement of eIF4AIII in the EJC is a regulated process that only 
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applies to some spliced mRNA so further testing would be necessary to determine if any 
nociceptor-specific spliced mRNAs are a target (Sauliere et al., 2010). 
eIF4A also plays a role in regulating alternative splicing, affecting splicing of para 
exons A and I (Park et al., 2004) TAF1 exons 12a and 13a (Katzenberger et al., 2009). As 
with eIF4AIII, additional testing would be necessary to determine whether eIF4A is affecting 
other targets in nociceptors. 
Regulation of alternative splicing is apparently a primary function for eIF3ga, which 
affected more than 300 splicing events in a recent study (Brooks et al., 2015). As previously 
discussed, eIF3ga shared a great deal of overlap in targets with alan shepard (Shep), which 
was also tested in this screen but had no phenotype. Given that eIF3ga was considered one of 
the more high-impact genes in this study, it would be worth testing loss-of-function mutants 
for splicing changes relevant to nociception (e.g. para, TrpA1 transcripts). 
Initiation Factors with Insensitive Phenotype: Regulation via Localization 
 As previously discussed, an important requirement for neuroplasticity is the ability of 
differential expression within the neuron, which necessitates localization of transcripts at 
axons and dendrites. Two RBPs with validated phenotypes are known to be involved in the 
localizing process. Although eIF4AIII is primarily known for its EJC role, this RBP also 
functions in oocytes as a component of an RNP complex responsible for the localization of 
oskar mRNA (Palacios et al., 2004) oskar mRNAs are also transported to md-da dendrites 
and the resulting regulatory proteins are necessary for normal development (Olesnicky et al., 
2014). It is possible that eIF4AIII could be involved in mRNA localization in other cell 
types, such as sensory neurons. eIF3ga has been found to associate with cytoskeletal proteins 
(Hou et al., 2000). Since interaction between mRNA and the cytoskeleton is a necessary 
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factor in localization (Bassell and Singer, 1997), eIF3ga may be serving as a link to the 
cytoskeleton for transport of mRNA, possibly in complex with other initiation factors or 
subunits. 
Initiation Factors with Insensitive Phenotype: Regulation via Less Common Mechanisms 
 Sometimes, the regulatory activity of initiation factors is itself regulated and 
knockdown yields surprising results. For instance, one study found that eIF1A mutations 
reduced general translation yet increased expression of yeast GCN4 (Fekete et al., 2005). The 
latter study is particularly interesting because yeast cells normally increase GCN4 translation 
when eIF2 is phosphorylated as a stress response to amino acid depletion, which renders 
GTP/eIF2/ tRNAi
Met ternary complexes (TCs) inactive. Under normal conditions, regulatory 
short open reading frames (ORFs) in the 5’ UTR of GCN4 transcripts slow down translation 
of functional GCN4 proteins. When the level of TCs is low due to inactivation, ribosomes are 
more likely to bypass 5’ UTR ORFs beyond the first as they wait for rebinding with TC, 
resulting in preferential binding to the start codon for GCN4 and increased expression 
(Hinnebusch, 1993). eIF1A guides the recruitment of the TC to the 40S subunit, and 
reduction of eIF1A may result in the same slowed scan rate that causes the 40S subunit to 
bypass regulatory UTR ORFs (Fekete et al., 2005; Li et al., 2014).  This counter-intuitive 
effect of eIF1A knockdown could also be the cause for the observed insensitive phenotype. 
 eIF4A also plays additional roles within cells. For instance, this RBP could be 
affecting a signalling pathway with a role in nociception. For instance, eIF4A was found to 
negatively regulate Dpp/BMP signalling through degradation of necessary proteins (Li and 
Li, 2006). eIF4A functions differently in ovarian germ stem cells, however; rather than 
regulating BMP signalling, it is able to bind directly with and inactivate BAM, thereby 
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promoting cell maintenance over differentiation (Shen et al., 2009). As an RNA helicase, 
eIF4A likely has additional roles in RNA metabolism to be discovered (Linder, 2006; Schwer 
and Meszaros, 2000) 
Initiation Factors with Insensitive Phenotype: Regulation via Stress Response and 
Alternative Translation Mechanisms 
Identifying six initiation factors with validated insensitive phenotypes supports the 
potential for translational control of nociception, but the number of necessary factors that 
apparently do not impact nociception must be considered. Additionally, one validated gene 
suggests an unexpected mechanism for translational regulation. As previously discussed, 
serine kinases are able to phosphorylate the alpha subunit of eIF2 when a cell is under stress, 
shutting down cap-dependent translation and activating cap-independent translation. The beta 
subunit provides eIF2 with the binding sites for eIF5 and eIF2B, necessary components for 
cap-dependent translation (Asano et al., 2000; Asano et al., 2001). Interestingly, RNAi 
knockdown of eIF2α resulted in an insensitive phenotype, but knockdown of eIF2β did not 
cause any abnormal nocifensive behavior. In other words, the subunit necessary for eIF2’s 
function in cap-dependent translation is apparently unnecessary for normal nociception. On 
the other hand, loss of the subunit necessary for deactivating eIF2 and shutting down cap-
dependent translation resulted in a nociception defect, indicating the potential for regulation 
of nociception via cap-independent translation, possibly as a previously unidentified stress 
response.  
Given that at least 3% of mRNAs in humans potentially contain an internal ribosome 
entry site (IRES) sequence and many of those identified are involved with stress responses 
(Johannes et al., 1999), it is certainly possible for cap-independent translation to be a factor 
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in nociception. This would also be consistent with the lack of phenotype found in knockdown 
of eIF5 and the presence of insensitive phenotype in only noncanonical 4G and 4E subunits. 
It would also explain eIF4G2’s lack of eIF5-binding domain. If eIF4G2 is involved in cap-
independent translation that does not require eIF5, the relevant binding domain would not be 
necessary. The noncanonical characteristics of eIF4E3 make more sense in this context as 
well. Involvement in atypical or stress-dependent translation would explain the lack of 
canonical regulation mechanisms.  
 eIF1A and eIF4A are both linked to somewhat minor roles in stress response. For 
instance, when genes encoding DNA repair enzymes are mutated in oocytes, a checkpoint 
activates that halts the process of meiosis in part by repressing Grk translation, yet mutating 
to eIF1A in these mutants restores Grk translation. This suggests eIF1A plays a role in this 
stress response pathway functioning appropriately, the mechanism of which has not been 
determined (Li et al., 2014). It was proposed that the presence of eIF1A may be necessary for 
repression of normal translation activity. eIF4A is an active component of the granules that 
form as part of stress response, possibly for the purpose of mRNA metabolism (Anderson 
and Kedersha, 2008), but the mechanisms of stress granules are still largely a mystery. It is 
possible that the helicase activity of eIF4A would be useful in cap-independent translation. 
IRESes have been found in the 5’ UTR of mRNAs localized in dendrites (Pinkstaff et al., 
2001), and eIF4A may play a role in unwinding these regions to read the mRNA for binding 
with its IRES.  
Although its specific function is unknown, one study has shown that eIF4A is vital to 
IRES-mediated translation (Thoma et al., 2004). The same study also established the poly-A 
tail and the requirement of a 4G subunit for binding. Moreover, cleavage of 4G subunits 
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impacted cap-dependent translation but stimulated IRES-mediated translation. This supports 
the potential for an IRES-specific subunit like eIF4G2 that can bind to eIF4E3 and the poly-
A tail but not eIF5, and therefore likely to be preferentially involved in cap-independent 
translation. It is also worth noting that human EIF4G1 and EIF4G2 contain IRES sequences 
(Johannes and Sarnow, 1998). 
 One characteristic that has already been demonstrated as shared by sensory neurons 
and IRES-mediated translation is the need for dendrite localization. In one study, five 
mRNAs were identified that were regularly translated via IRES in addition to cap-dependent 
mechanisms, and that IRES-mediated translation was more efficient in the dendrites than cell 
body. These mRNAs equipped with IRES sequences in their 5’ UTR were continuously 
expressed, even in conditions that caused general expression levels to fall (Pinkstaff et al., 
2001). In Aplysia californica, an egg-laying hormone increases expression in response to the 
physiological signal to lay eggs. It was determined that this happens via IRES-mediated 
translation (Dyer et al., 2003). This study provides a basis for physiological stimulus 
activating IRES-mediated translation, and underscores the importance of this translation 
method at synapses due to a limited ribosome population. The same has been found true in 
axons, where recovery of sensory neurons from the physiological distress of photobleaching 
was accomplished via IRES-mediated translation occurring in axons (Pacheco and Twiss, 
2012).  
 There is a great deal of support for the possibility that there is a nociceptor-specific 
means of translation that functions independently of the 5’ cap. All seven validated RBPs 
could be playing either a direct role in this mechanism or an indirect role (e.g. localization). 
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Further research is needed, but if this is indeed the case, it presents eIF2α as a potential 
treatment target (Kim et al., 2012). 
Validated Hypersensitive Phenotype: eIF2Bα 
eIF2B is an interesting RBP made up of 5 different subunits, each one serving as a 
target for one or more different regulators, making eIF2B a component of a wide range of 
diverse mechanisms (Pavitt, 2005). The α subunit serves as a target for eIF2α. When kinases 
such as GCN2, PERK, PKR, or HRI are activated, these stress-response kinases and 
translation inhibitors phosphorylate eIF2α, which increases its affinity for binding with 
eIF2Bα, rendering eIF2B inactive. 
 It is surprising that knockdown of this gene produced the opposite phenotype from 
knocking down eIF2α. One possible explanation is that the two inactivations serve different 
purposes. For instance, nociception may be dependent on eIF2α phosphorylation to start the 
cascade of signaling events that make conditions more favorable for cap-independent 
translation. If inactivation of eIF2B is the end of that particular chain and not needed to 
trigger any other reaction, the opposite phenotypes could make sense. Nociception may be 
dependent on eIF2α phosphorylation as a trigger for other events and would be inhibited by 
lack of eIF2α expression. If nociception function is enhanced by inactivation of eIF2B, 
knocking down eIF2Bα expression could also enhance nociception if the lack of that subunit 
interferes with eIF2B function. Active eIF2α binds with eIF2B via its alpha unit in the course 
of normal cap-dependent translation, so lacking eIF2Bα could cause repressed cap-dependent 
translation and enhance IRES-mediated translation. 
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Validated Hypersensitive Phenotype: Pumilio 
Pumilio (Pum) is a known translation repressor, regulating both cap-dependent and 
IRES-mediated translation, depending on cell type and context (Wharton et al., 1998). One 
known Pum function is regulation of neuronal excitability through repression of para 
translation. In one study, para overexpression and pum knockdown both resulted in 
hyperexcitability, but this term was described as a faster onset of sensitization following 
prolonged stimulation (Mee et al., 2004; Schweers et al., 2002). Given the experiments 
described in the study, it seems unlikely that latency in a thermal nociception assay would 
trigger this type of hyperexcitability.  
Additionally, Pum repression of para mRNA in neurons apparently requires Nanos in 
all types of neurons and Brat in some types (Muraro et al., 2008), but neither Nanos nor Brat 
exhibited a phenotype in this screen. Thermal nociception assays on mutants overexpressing 
para could be illuminating if a hypersensitive phenotype results, but interaction with para 
may not be reason for pum’s phenotype. Pum also has a known role in regulating synaptic 
function in the neuromuscular junction but its activity in that context is postsynaptic (Menon 
et al., 2004) and may not be relevant. 
Hundreds of genes are subject to regulation by Pum (Gerber et al., 2006) and finding 
the target resulting in this phenotype could be difficult. One possible target that would be 
particularly useful if identified is TrpA1-A. This isoform activates at 24-29°C, well below 
normal nociception threshold (Viswanath et al., 2003). Ectopic expression of this isoform in 
nociceptors causes a nocifensive reaction in the lower temperature range (Zhong et al., 2012). 
It is possible that TrpA1-A transcripts are present in nociceptors but repressed under normal 
circumstances (e.g. by Pum) and that injury activates their translation. This type of 
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mechanism could explain the development of allodynia, in which skin becomes more 
sensitive to stimuli following injury. 
Future Directions 
The results from this screen have opened up numerous avenues for potential future 
research. Hits that have not been validated will need to be tested more thoroughly. 
Additionally, completing a full screen at 42°C of all genes that did not exhibit a phenotype 
could identify additional hits with a hypersensitive phenotype. It would also be beneficial to 
pursue molecular experiments with validated hits from either or both screens.  
Using Channelrhodopsin-2 from green algae to produce light-activated nociceptors in 
target gene mutants would be the next step to discern defects in signal reception versus 
transmission (Hwang et al., 2007), particularly when nociception defects occur in 
conjunction with dendritic defects. It is important to note that these thermal assays involved 
stimulation of 2-3 segments of the body wall; therefore, it is likely that in nociceptors with 
morphological abnormalities and normal nocifensive response, the dendrites are still 
functioning normally and were stimulated by the probe. In cases of dendrite abnormalities 
combined with a nociception defect, it is possible that the defect causing abnormal 
morphology also resulted in dysfunctional behavior. However, the lack of correlation 
indicates the potential for defect causes unrelated to dendrite functionality.  
Given the previously discussed lack of correlation with identified splicing targets, it 
would also be worthwhile to evaluate potential splicing regulators for impact on splicing 
events affecting nociception. PCR could be used to identify any changes in splicing targets of 
interest. eIF4A, eIF4AIII, and eIF3ga are particularly strong candidates to evaluate for 
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effects on alternative splicing. eIF2Bα and pumilio should also be evaluated due to their 
hypersensitive phenotype, which indicates potential expression of TrpA1-A. 
 The role of Pum will also require additional testing to discover its target for 
repression. Larvae overexpressing Para could be tested for hypersensitivity. Testing for 
binding of Pum with TrpA1 mRNA, isoform A in particular, would also be useful. Other 
translation repressors expressed in sensory neurons could also be considered. If there are 
repressed TrpA1-A transcripts maintained in nociceptors, a low-temperature screen of RNA-
binding proteins could help to identify the repressor involved. 
 Finally, the possibility of a mode of translation specific to proteins that enable 
sensory transduction in nociceptors, possibly IRES-mediated, should be explored. Binding 
between eIF4G2 and eIF4E3 in nociceptors should be tested. Loss-of-function behavioral 
testing of Gcn2 and PEK kinases in nociceptors is another option. If nociception is dependent 
on phosphorylation of eIF2α, eliminating the kinase responsible for phosphorylating eIF2α in 
nociceptors should produce the same phenotype as eIF2α-RNAi. 3’ and 5’ UTRs of mRNAs 
relevant to nociception could also be analyzed for IRES sequences. 
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Appendix A: Stocks Tested 
 
VDRC 
CG # Stock #   CG # Stock #   CG # Stock # 
CG3193 39335 GD   CG4528 104334 KK   CG9809 103355 KK 
CG5454 22132 GD   CG12759 104183 KK   CG4396 101508 KK 
CG12924 108336 KK   CG9696 7787 GD   CG5637 108900 KK 
CG8241 47782 GD   CG7185 107147 KK   CG9755 45815 GD 
CG10418 105940 KK   CG4119 26395 GD   CG9373 44658 GD 
CG12085 20144 GD   CG9075 42202 GD   CG6203 8933 GD 
CG7437 105495 KK   CG4602 51088 GD   CG14648 110736 KK 
CG9998 24176 GD   CG33197 105486 KK   CG11334 109672 KK 
CG8144 24214 GD   CG31061 106079 KK   CG5589 108642 KK 
CG7269 22557 GD   CG9218 108351 KK   CG14718 105543 KK 
CG5931 43962 GD   CG10084 105950 KK   CG32706 109212 KK 
CG14641 38790 GD   CG17492 108947 KK   CG6961 109951 GD 
CG6841 34253 GD   CG17686 108186 KK   CG6418 108552 KK 
CG2926 33589 GD   CG9680 108310 KK   CG18259 50094 GD 
CG10445 104753 KK   CG10203 100226 KK   CG40351 40683 GD 
CG6227 110778 KK   CG6866 108358 KK   CG5168 110451 KK 
CG3582 110075 KK   CG6375 106078 KK   CG5705 108376 KK 
CG31762 107459 KK   CG13425 105271 KK   CG10777 109465 KK 
CG16941 20338 GD   CG5605 45027 GD   CG7903 106475 KK 
CG12749 51759 GD   CG10719 105054 KK   CG11505 105949 KK 
CG11360 38491 GD   CG6539 49506 GD   CG8053 100611 KK 
CG8749 23150 GD   CG32423 37863 GD   CG9946 104562 KK 
CG6197 104186 KK   CG33100 38399 GD   CG4153 105291 KK 
CG10851 38860 GD   CG16901 32395 GD   CG8882 103141 KK 
CG10210 38356 GD   CG9054 103365 KK   CG8636 105325 KK 
CG5442 104978 KK   CG6779 106321 KK   CG9769 101465 KK 
CG10128 8868 GD   CG4792 106041 KK   CG4878 107829 KK 
CG10851 38860 GD   CG33106 103411 KK   CG10124 107595 KK 
CG16724 2560 GD   CG8730 108026 KK   CG8280 104502 KK 
CG8019 41023 GD   CG9412 109911 KK   CG1873 102736 KK 
CG6999 41828 GD             
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TRiP (Bloomington) 
CG # Stock #   CG # Stock #   CG # Stock # 
CG6946 36066   CG17454 43199   CG10279 31395 
CG5263 35477   CG5422 28035   CG12413 41839 
CG10868 25843   CG9177 34841   CG4035 34096 
CG6493 27486   CG10840 44418   CG10192 35809 
CG4262 28371   CG10837 57305   CG3845 32357 
CG6137 35201   CG10306 44493   CG7883 55624 
CG1691 34977   CG7483 32444   CG8023 42804 
CG10293 55665   CG10811 33049   CG6995 51759 
CG42320 55908   CG5728 55916   CG9124 55603 
 
 
NIG 
CG # Stock #   CG # Stock # 
CG11266 11266R-3   CG5439 5439R-1 
CG17540 17540R   CG3056 3056R-1 
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Appendix B: Fly Food Protocol 
 
The maintenance of a healthy fly colony absolutely depends on consistent fly food quality 
and production. We have previously found that nociception-related behaviors (and likely 
other behaviors as well) are highly dependent on food composition and quality. Thus it is 
essential maintain a rigorous protocol for cooking fly food of standard composition, and 
continuously monitor that food for quality and consistency. We are currently using the Nutri-
Fly Molasses Formulation produced by Genesee Scientific in 1L pouches (#66-116). Using 
this formulation, one pouch produces enough food for 4-6 bottles and 75-90 vials. We are 
cooking one pouch of food a week currently, but this protocol should be easily scaled to two 
or three pouches. 
 
1. Obtain 1L deionized water from purification system in 3rd floor autoclave room. Empty 
one pouch of Nutri-Fly MF into a two-liter Erlenmeyer flask and add ~500ml of deionized 
water. Swirl flask vigorously to fully suspend solids and break up any large chunks. 
 
2. Add a large stir bar to the flask as well as the remaining ~500ml of deionized water. The 
water can be used to wash off any solids stuck around the walls of the flask. 
 
3. Set stirring hot plate to ~300°C and stirring speed to 6 on the dial. Cover the flask with 
aluminum foil and place it on the hot plate and make sure that you are getting vigorous 
stirring (i.e. a big whirlpool in the center of the flask). The speed will need to be adjusted 
upward as it thickens (up to 7.5). 
 
4. Cook the food until it reaches a rolling boil, which takes approximately 35 minutes. Watch 
closely during the last 5-10 minutes to prevent the food from boiling over.  
 
5. When food reaches boiling, turn the temperature of the hot plate to 135°C, remove the foil 
cover, and set timer for 15 minutes (simmer time). If covered, the food will threaten to 
boil over. Once food has settled down, replace cover. Continue simmering with foil cover 
in place until timer is finished. Remove from heat when finished and turn the hot plate 
temperature to zero. 
 
6. When flask has cooled for 10 minutes, return the flask to stir plate and stir at speed 6. 
Add 4.8ml of 99% propionic acid [and 10 mL Tegosept when applicable]. Replace 
cover, set stir speed to 7-7.5, and stir for an additional 5 minutes. During this time, fill 
food dispenser tank to appropriate water level, which is marked inside the tank (~500 ml). 
 
7. Pour the liquid food into the dispenser, put pump/cover in place, and turn on dispenser. 
Flask should be washed immediately with very hot water. Dispense food into vials and 
bottles. Spacers can be used on the pump handle such that one pump will dispense 
approximately 3-4cm of food into a polypropylene narrow vial, which is a good target 
amount. Several pumps will be required to dispense a similar height into a glass bottle. 
When you have finished dispensing, there will be enough food left in the dispenser to pour 
into 2 additional bottles (if prepared food can be used for stocks). 
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8. The inner tank and pump/cover of the food dispenser must be washed immediately with 
very hot water. Any remaining food must be significantly diluted in very hot water to 
prevent solidification of the food, which will clog pipes. Be sure to dispense hot water 
through the pump until it runs clear. 
 
9. Label boxes clearly with date and purpose, i.e. “for crosses” or “for stocks” and 
“+tego” for any food containing Tegosept. Food should be allowed to dry at room 
temperature for approximately 24 hours. Cover food with cheesecloth to prevent 
infestation by escaped flies. 
 
10. Plug food and store at 4°C once drying time is complete. Most, if not all, condensation 
should be evaporated from the walls of the vials and bottles at this point. 
 
Notes: Food humidity is often the biggest source of variation in food quality. Water levels 
and drying time can be adjusted if batches of food are noticed to either be peeling away from 
the walls of their containers or accumulating water on their surface. 
 
Materials and equipment: 
Nutri-Fly MF packets (Genesee Scientific #66-116) 
Stirring hot plate 
Water-heated hot fudge dispenser (for dispensing food) 
99% propionic acid in water (Genesee Scientific #20-271) 
Cheesecloth (Genesee Scientific #53-100) 
Polypropylene narrow vials with cotton ball plugs (Genesee Scientific #32-120BC) 
Glass fly bottles 
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Appendix C: Video Analysis Protocol 
 
1. Open Adobe Premiere Pro. 
2. Choose “New Project.” 
3. Enter a file name if desired, then click “OK.” 
4. Click “OK” on the “New Sequence” window that opens. 
5. Click on the File menu and choose “Import…” (Shortcut: Ctrl+I). 
6. Choose video for analysis and click “Open.” 
7. The video will appear in the “Project” pane in the bottom left corner. Drag the video to the 
“Video 1” track in the “Sequence” pane (to the right of the Project pane). A “Clip 
Mismatch Warning” will appear; click “Change sequence settings.”  
8. If running the program for the first time, the video will appear in the top right corner. 
Click on the menu icon in the top right corner of the video panel and select “Undock 
Frame.” You can now drag the frame to the left-hand monitor and resize it to fit screen. 
9. Click on the time scroll bar at the bottom of the video to make it active. 
10. Using the left and right arrow keys will advance or reverse the video one frame at a time. 
Shift+arrow will advance or reverse five frames at a time (useful for moving quickly to 
next trial). 
11. Create an Excel spreadsheet to enter information for the video being analyzed.  
a. Enter each trial as a separate row with two columns for start/stop times. The moment 
of probe connecting with larva is recorded as “start time.” The moment of roll 
completion (or >10 sec) is “stop time.” Record data for each larva in the spreadsheet as 
you progress through your video. Label each cross appropriately to keep data separate. 
b. Video time is shown as hh:mm:ss:ff. “ff” indicates number of frames. There are 30 
frames per second, so 3 frames = 0.1 sec. Round to the nearest tenth. Examples:  
 00:00:03:10 is 3 seconds and 10 frames, which can be rounded to 3 seconds and 9 
frames, or 3.3 seconds.  
 00:00:03:29 is 3 seconds and 29 frames, which can be rounded to 3 seconds and 30 
frames, or 4.0 seconds. 
c. Create an additional column to automatically calculate latency between start and stop 
time (subtract start time from stop time).  
d. Only input time point data required to calculate latency (i.e. don’t include minutes). 
Although a start time greater than 50 seconds will require a stop time greater than 60 
seconds to calculate properly, enter the time as seconds, not minutes (i.e. 58:06 - 01:16 
becomes start time: 58.2; stop time: 61.5; and 61.5 - 58.2 = 3.3 seconds latency).  
e. See Page 2 for example of video data spreadsheet. 
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Sample: data collection and spreadsheet 
 
Video Start/Stop times:   Start/Stop time converted to seconds: 
1. 00:00:31:06, 00:00:38:13  [31.2, 38.4]  
2. 00:01:58:29, 00:02:04:07  [59, 64.2] 
3. 00:03:21:06, 00:03:34:16  [21.2, 34.5] 
4. 00:04:56:11, 00:05:06:17  [56.4, 66.6] 
5. 00:06:46:04, 00:06:49:12  [46.1, 49.4] 
6. 00:07:31:02, 00:07:42:22  [31.1, 42.7] 
7. 00:0848:24, 00:08:54:28  [48.8, 54.9] 
8. 00:9:49:28, 00:10:02:13  [49.9, 62.4] 
9. 00:11:19:13, 00:11:32:03  [19.4, 32.1] 
10. 00:13:29:14, 00:13:38:06  [29.5, 38.2] 
11. 00:14:27:08, 00:14:37:07  [27.3, 37.2] 
12. 00:16:03:11, 00:16:09:11  [3.4, 9.4] 
13. 00:17:34:16, 00:17:46:06  [34.5, 46.2] 
14. 00:18:14:08, 00:18:24:04  [14.3, 24.1] 
 
Corresponding spreadsheet layout: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Column D contains formulas, e.g. “=C7-B7” in D7, “=C8-B8” in D8, etc.)  
 A B C D 
1 Assay Date: 7/9/15  
2 Cross Date: 7/2/15  
3 Gene tested: CG2926  
4 Filename: 20150709b.mts  
5     
6 Trial Start Stop Latency 
7 1 31.2 38.4 7.2 
8 2 59 64.2 5.2 
9 3 21.2 34.5 13.3 
10 4 56.4 66.6 10.2 
11 5 46.1 49.4 3.3 
12 6 31.1 42.7 11.6 
13 7 48.8 54.9 6.1 
14 8 49.9 62.4 12.5 
15 9 19.4 32.1 12.7 
16 10 29.5 38.2 8.7 
17 11 27.3 37.2 9.9 
18 12 3.4 9.4 6 
19 13 34.5 46.2 11.7 
20 14 14.3 24.1 9.8 
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Appendix D: Statistics 
 
Wild-Type Data Comparison 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks: 
Group N Missing Median 25% 75% 
isoW 278 0 3.2 2.3 4.4 
y w; attp 440 0 2.9 2 3.8 
y v; attP2, y+ 155 0 2.3 1.5 3.1 
y v; attP40, y+ 54 0 2.8 2 3.725 
w1118 72 0 2.9 1.925 3.975 
 
H = 53.911 with 4 degrees of freedom.  (p < 0.001) 
The differences in the median values among the treatment groups are greater than would be 
expected by chance; there is a statistically significant difference (p < 0.001) 
All Pairwise Multiple Comparison Procedures (Dunn's Method): 
Comparison Diff of Ranks Q P P < 0.050 
isoW vs y v; attP2, y+ 211.169 7.301 <0.001 Yes 
isoW vs attP40 78.498 1.829 0.673 No 
isoW vs W[1118] 70.968 1.86 0.629 Do Not Test 
isoW vs yw; attp 61.63 2.788 0.053 Do Not Test 
y w; attp vs y v; attP2, y+ 149.54 5.549 <0.001 Yes 
y w; attp vs y v; attP40, y+ 16.868 0.405 1 Do Not Test 
y w; attp vs w1118 9.338 0.255 1 Do Not Test 
w1118 vs y v; attP2, y+ 140.202 3.407 0.007 Yes 
w1118 vs y v; attP40, y+ 7.53 0.145 1 Do Not Test 
y v; attP40, y+ vs y v; attP2, y+ 132.672 2.91 0.036 Yes 
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Validations 
Kruskal-Wallis One Way Analysis of Variance on Ranks (y v; attP2, y+ wild-type 
background) 
Group N Missing Median 25% 75% 
y v; attP2, y+ 58 0 2.35 1.775 3.5 
eIF4G2 RNAi 55 0 2.9 2 4 
eIF4AIII RNAi 54 0 3.8 2.15 6.625 
eIF4E3 RNAi 52 0 3.35 2.35 4.575 
H = 18.972 with 3 degrees of freedom.  (p < 0.001) 
The differences in the median values among the treatment groups are greater than would be 
expected by chance; there is a statistically significant difference (p < 0.001). 
Multiple Comparisons versus Control Group (Dunn's Method) 
Comparison Diff of Ranks Q P P < 0.050 
eIF4AIII RNAi vs y v; attP2, y+ 49.7 4.148 <0.001 Yes 
eIF4E3 RNAi vs y v; attP2, y+ 37.998 3.14 0.005 Yes 
eIF4G2 RNAi vs y v; attP2, y+ 29.481 2.472 0.040 Yes 
 
 
 
Kruskal-Wallis One Way Analysis of Variance on Ranks (y w; attp wild-type background) 
Group N Missing Median 25% 75% 
y w; attp 61 0 2.8 2.05 3.65 
eIF1A RNAi 63 0 8.4 6.5 11 
eIF2α RNAi 63 0 4.5 2.5 6.3 
eIF3ga RNAi 66 0 4.5 2.875 6.1 
H = 92.884 with 3 degrees of freedom.  (p < 0.001) 
The differences in the median values among the treatment groups are greater than would be 
expected by chance; there is a statistically significant difference (p < 0.001). 
Multiple Comparisons versus Control Group (Dunn's Method) 
Comparison Diff of Ranks Q P P < 0.050 
eIF1A RNAi vs y w; attp 125.152 9.521 <0.001 Yes 
eIF3ga RNAi vs y w; attp 52.965 4.075 <0.001 Yes 
eIF2α RNAi vs y w; attp 48.43 3.684 <0.001 Yes 
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Mann-Whitney Rank Sum Test (eIF4A RNAi) 
Group N Missing Median 25% 75% 
eIF4A RNAi 77 0 6 3.7 8.1 
isoW 79 0 2.5 1.6 3.3 
Mann-Whitney U Statistic= 847.500 
T = 8238.500  n(small)= 77  n(big)= 79  (p < 0.001) 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (p < 0.001). 
 
Mann-Whitney Rank Sum Test (eIF2Bα RNAi) 
 
Group N Missing Median 25% 75% 
eIF2Bα RNAi 61 0 8.1 5.2 11 
y v; attP40, y+ 51 0 11 7.9 11 
 
Mann-Whitney U Statistic= 1037.000 
T = 3400.000  n(small)= 51  n(big)= 61  (p = 0.001) 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (p = 0.001). 
 
Mann-Whitney Rank Sum Test (pumilio RNAi) 
 
Group N  Missing 
 
Median  25% 75% 
pumilio RNAi 51 0 4.7 3.6 6.4 
y v; attP2, y+ 45 0 6.1 4.2 10.05 
 
Mann-Whitney U Statistic= 858.000 
T = 2472.000  n(small)= 45  n(big)= 51  (p = 0.034) 
 
The difference in the median values between the two groups is greater than would be 
expected by chance; there is a statistically significant difference (p = 0.034). 
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